Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for SP1
Z-value: 3.42
Motif logo
Transcription factors associated with SP1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SP1
|
ENSG00000185591.5 | Sp1 transcription factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SP1 | hg19_v2_chr12_+_53773944_53773993 | 0.76 | 1.0e-04 | Click! |
Activity profile of SP1 motif
Sorted Z-values of SP1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr3_+_50192457 | 20.21 |
ENST00000414301.1
ENST00000450338.1 |
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr14_+_94640633 | 16.87 |
ENST00000304338.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
| chr3_+_50192499 | 16.13 |
ENST00000413852.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr3_+_50192537 | 15.97 |
ENST00000002829.3
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr5_-_141257954 | 14.75 |
ENST00000456271.1
ENST00000394536.3 ENST00000503492.1 ENST00000287008.3 |
PCDH1
|
protocadherin 1 |
| chr19_-_51504852 | 14.57 |
ENST00000391806.2
ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8
|
kallikrein-related peptidase 8 |
| chr2_+_14772810 | 14.55 |
ENST00000295092.2
ENST00000331243.4 |
FAM84A
|
family with sequence similarity 84, member A |
| chr7_-_143892748 | 14.01 |
ENST00000378115.2
|
ARHGEF35
|
Rho guanine nucleotide exchange factor (GEF) 35 |
| chr6_+_41606176 | 13.92 |
ENST00000441667.1
ENST00000230321.6 ENST00000373050.4 ENST00000446650.1 ENST00000435476.1 |
MDFI
|
MyoD family inhibitor |
| chr5_+_131593364 | 13.92 |
ENST00000253754.3
ENST00000379018.3 |
PDLIM4
|
PDZ and LIM domain 4 |
| chr18_+_33877654 | 13.87 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
| chr7_-_143991230 | 13.76 |
ENST00000543357.1
|
ARHGEF35
|
Rho guanine nucleotide exchange factor (GEF) 35 |
| chr3_+_50192833 | 13.31 |
ENST00000426511.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr11_-_94964354 | 13.17 |
ENST00000536441.1
|
SESN3
|
sestrin 3 |
| chr6_+_149638876 | 13.03 |
ENST00000392282.1
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
| chr11_-_94964210 | 12.22 |
ENST00000416495.2
ENST00000393234.1 |
SESN3
|
sestrin 3 |
| chr8_+_1711918 | 12.15 |
ENST00000331222.4
|
CLN8
|
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) |
| chr14_+_94640671 | 12.15 |
ENST00000328839.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
| chr15_+_41136216 | 12.02 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr22_+_33197683 | 11.87 |
ENST00000266085.6
|
TIMP3
|
TIMP metallopeptidase inhibitor 3 |
| chr7_+_144052381 | 11.71 |
ENST00000498580.1
ENST00000056217.5 |
ARHGEF5
|
Rho guanine nucleotide exchange factor (GEF) 5 |
| chr13_-_52027134 | 11.67 |
ENST00000311234.4
ENST00000425000.1 ENST00000463928.1 ENST00000442263.3 ENST00000398119.2 |
INTS6
|
integrator complex subunit 6 |
| chr3_-_13921594 | 11.50 |
ENST00000285018.4
|
WNT7A
|
wingless-type MMTV integration site family, member 7A |
| chr8_-_124286735 | 11.43 |
ENST00000395571.3
|
ZHX1
|
zinc fingers and homeoboxes 1 |
| chr11_+_57365150 | 11.29 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
| chr6_+_43739697 | 11.24 |
ENST00000230480.6
|
VEGFA
|
vascular endothelial growth factor A |
| chr1_-_153588765 | 11.20 |
ENST00000368701.1
ENST00000344616.2 |
S100A14
|
S100 calcium binding protein A14 |
| chr16_-_31147020 | 10.96 |
ENST00000568261.1
ENST00000567797.1 ENST00000317508.6 |
PRSS8
|
protease, serine, 8 |
| chr11_-_119187826 | 10.96 |
ENST00000264036.4
|
MCAM
|
melanoma cell adhesion molecule |
| chr6_+_44095347 | 10.83 |
ENST00000323267.6
|
TMEM63B
|
transmembrane protein 63B |
| chr10_-_75634219 | 10.39 |
ENST00000305762.7
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
| chr12_-_6715808 | 10.37 |
ENST00000545584.1
|
CHD4
|
chromodomain helicase DNA binding protein 4 |
| chr6_+_44095263 | 10.36 |
ENST00000532634.1
|
TMEM63B
|
transmembrane protein 63B |
| chr12_+_4382917 | 10.33 |
ENST00000261254.3
|
CCND2
|
cyclin D2 |
| chr2_+_70142232 | 10.24 |
ENST00000540449.1
|
MXD1
|
MAX dimerization protein 1 |
| chr4_+_152330390 | 10.23 |
ENST00000503146.1
ENST00000435205.1 |
FAM160A1
|
family with sequence similarity 160, member A1 |
| chr16_-_68269971 | 10.15 |
ENST00000565858.1
|
ESRP2
|
epithelial splicing regulatory protein 2 |
| chr3_+_135684515 | 10.01 |
ENST00000264977.3
ENST00000490467.1 |
PPP2R3A
|
protein phosphatase 2, regulatory subunit B'', alpha |
| chr5_-_2751762 | 9.95 |
ENST00000302057.5
ENST00000382611.6 |
IRX2
|
iroquois homeobox 2 |
| chr2_-_230786378 | 9.93 |
ENST00000430954.1
|
TRIP12
|
thyroid hormone receptor interactor 12 |
| chr12_+_1100449 | 9.91 |
ENST00000360905.4
|
ERC1
|
ELKS/RAB6-interacting/CAST family member 1 |
| chr15_+_41136586 | 9.88 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr4_+_85504075 | 9.82 |
ENST00000295887.5
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 |
| chr16_+_68679193 | 9.81 |
ENST00000581171.1
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
| chr2_+_10091815 | 9.68 |
ENST00000324907.9
|
GRHL1
|
grainyhead-like 1 (Drosophila) |
| chr3_-_176915215 | 9.63 |
ENST00000457928.2
ENST00000422442.1 |
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1 |
| chr8_+_95653302 | 9.60 |
ENST00000423620.2
ENST00000433389.2 |
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr2_+_173292059 | 9.56 |
ENST00000412899.1
ENST00000409532.1 |
ITGA6
|
integrin, alpha 6 |
| chr11_+_129939811 | 9.52 |
ENST00000345598.5
ENST00000338167.5 |
APLP2
|
amyloid beta (A4) precursor-like protein 2 |
| chr12_+_1100370 | 9.44 |
ENST00000543086.3
ENST00000546231.2 ENST00000397203.2 |
ERC1
|
ELKS/RAB6-interacting/CAST family member 1 |
| chr17_+_79008940 | 9.24 |
ENST00000392411.3
ENST00000575989.1 ENST00000321280.7 ENST00000428708.2 ENST00000575712.1 ENST00000575245.1 ENST00000435091.3 ENST00000321300.6 |
BAIAP2
|
BAI1-associated protein 2 |
| chr10_-_105615164 | 9.24 |
ENST00000355946.2
ENST00000369774.4 |
SH3PXD2A
|
SH3 and PX domains 2A |
| chr19_+_10713112 | 9.16 |
ENST00000590382.1
ENST00000407327.4 |
SLC44A2
|
solute carrier family 44 (choline transporter), member 2 |
| chr17_+_7341586 | 9.14 |
ENST00000575235.1
|
FGF11
|
fibroblast growth factor 11 |
| chr2_-_9143786 | 9.11 |
ENST00000462696.1
ENST00000305997.3 |
MBOAT2
|
membrane bound O-acyltransferase domain containing 2 |
| chr1_-_209979375 | 9.10 |
ENST00000367021.3
|
IRF6
|
interferon regulatory factor 6 |
| chr2_+_173292390 | 9.07 |
ENST00000442250.1
ENST00000458358.1 ENST00000409080.1 |
ITGA6
|
integrin, alpha 6 |
| chr6_+_43044003 | 9.06 |
ENST00000230419.4
ENST00000476760.1 ENST00000471863.1 ENST00000349241.2 ENST00000352931.2 ENST00000345201.2 |
PTK7
|
protein tyrosine kinase 7 |
| chr16_+_68678892 | 9.04 |
ENST00000429102.2
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
| chr3_-_176915036 | 8.98 |
ENST00000427349.1
ENST00000352800.5 |
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1 |
| chr17_-_39743139 | 8.95 |
ENST00000167586.6
|
KRT14
|
keratin 14 |
| chr12_-_28123206 | 8.95 |
ENST00000542963.1
ENST00000535992.1 |
PTHLH
|
parathyroid hormone-like hormone |
| chr9_-_122131696 | 8.93 |
ENST00000373964.2
ENST00000265922.3 |
BRINP1
|
bone morphogenetic protein/retinoic acid inducible neural-specific 1 |
| chr10_-_28591981 | 8.91 |
ENST00000445954.2
|
MPP7
|
membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) |
| chr22_+_31644388 | 8.88 |
ENST00000333611.4
ENST00000340552.4 |
LIMK2
|
LIM domain kinase 2 |
| chr5_+_9546306 | 8.80 |
ENST00000508179.1
|
SNHG18
|
small nucleolar RNA host gene 18 (non-protein coding) |
| chr1_-_209979465 | 8.79 |
ENST00000542854.1
|
IRF6
|
interferon regulatory factor 6 |
| chr22_-_43583079 | 8.79 |
ENST00000216129.6
|
TTLL12
|
tubulin tyrosine ligase-like family, member 12 |
| chr15_-_75017711 | 8.73 |
ENST00000567032.1
ENST00000564596.1 ENST00000566503.1 ENST00000395049.4 ENST00000395048.2 ENST00000379727.3 |
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1 |
| chr8_+_95653427 | 8.64 |
ENST00000454170.2
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr19_-_49568311 | 8.56 |
ENST00000595857.1
ENST00000451356.2 |
NTF4
|
neurotrophin 4 |
| chrX_-_48326764 | 8.47 |
ENST00000413668.1
ENST00000441948.1 |
SLC38A5
|
solute carrier family 38, member 5 |
| chr8_-_124286495 | 8.44 |
ENST00000297857.2
|
ZHX1
|
zinc fingers and homeoboxes 1 |
| chr6_+_18155560 | 8.42 |
ENST00000546309.2
ENST00000388870.2 ENST00000397244.1 |
KDM1B
|
lysine (K)-specific demethylase 1B |
| chr4_-_102268708 | 8.41 |
ENST00000525819.1
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
| chrX_+_43515467 | 8.40 |
ENST00000338702.3
ENST00000542639.1 |
MAOA
|
monoamine oxidase A |
| chr17_-_58469687 | 8.32 |
ENST00000590133.1
|
USP32
|
ubiquitin specific peptidase 32 |
| chr12_+_1100423 | 8.24 |
ENST00000592048.1
|
ERC1
|
ELKS/RAB6-interacting/CAST family member 1 |
| chr8_+_26149274 | 8.23 |
ENST00000522535.1
|
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha |
| chr16_+_68678739 | 8.21 |
ENST00000264012.4
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
| chr21_-_28217721 | 8.17 |
ENST00000284984.3
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
| chr1_-_156675564 | 8.16 |
ENST00000368220.1
|
CRABP2
|
cellular retinoic acid binding protein 2 |
| chr6_-_35464817 | 8.15 |
ENST00000338863.7
|
TEAD3
|
TEA domain family member 3 |
| chr19_+_35606692 | 8.14 |
ENST00000406242.3
ENST00000454903.2 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
| chr1_-_156675535 | 8.11 |
ENST00000368221.1
|
CRABP2
|
cellular retinoic acid binding protein 2 |
| chr9_+_110045418 | 8.03 |
ENST00000419616.1
|
RAD23B
|
RAD23 homolog B (S. cerevisiae) |
| chr10_+_111767720 | 8.01 |
ENST00000356080.4
ENST00000277900.8 |
ADD3
|
adducin 3 (gamma) |
| chr4_+_152330409 | 7.94 |
ENST00000513086.1
|
FAM160A1
|
family with sequence similarity 160, member A1 |
| chr11_+_44587141 | 7.93 |
ENST00000227155.4
ENST00000342935.3 ENST00000532544.1 |
CD82
|
CD82 molecule |
| chr11_+_129939779 | 7.87 |
ENST00000533195.1
ENST00000533713.1 ENST00000528499.1 ENST00000539648.1 ENST00000263574.5 |
APLP2
|
amyloid beta (A4) precursor-like protein 2 |
| chr6_+_150464155 | 7.81 |
ENST00000361131.4
|
PPP1R14C
|
protein phosphatase 1, regulatory (inhibitor) subunit 14C |
| chr6_-_86353510 | 7.80 |
ENST00000444272.1
|
SYNCRIP
|
synaptotagmin binding, cytoplasmic RNA interacting protein |
| chr1_-_6321035 | 7.78 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
| chr1_+_211432775 | 7.77 |
ENST00000419091.2
|
RCOR3
|
REST corepressor 3 |
| chr14_+_52118576 | 7.76 |
ENST00000395718.2
ENST00000344768.5 |
FRMD6
|
FERM domain containing 6 |
| chr22_+_31644309 | 7.76 |
ENST00000425203.1
|
LIMK2
|
LIM domain kinase 2 |
| chr2_+_173292301 | 7.74 |
ENST00000264106.6
ENST00000375221.2 ENST00000343713.4 |
ITGA6
|
integrin, alpha 6 |
| chr8_-_99837856 | 7.72 |
ENST00000518165.1
ENST00000419617.2 |
STK3
|
serine/threonine kinase 3 |
| chr5_-_132299290 | 7.71 |
ENST00000378595.3
|
AFF4
|
AF4/FMR2 family, member 4 |
| chr3_-_48130707 | 7.70 |
ENST00000360240.6
ENST00000383737.4 |
MAP4
|
microtubule-associated protein 4 |
| chr18_+_29078131 | 7.69 |
ENST00000585206.1
|
DSG2
|
desmoglein 2 |
| chr8_+_95653373 | 7.68 |
ENST00000358397.5
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr19_-_51472031 | 7.66 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr2_+_47596634 | 7.65 |
ENST00000419334.1
|
EPCAM
|
epithelial cell adhesion molecule |
| chr14_-_71276211 | 7.62 |
ENST00000381250.4
ENST00000555993.2 |
MAP3K9
|
mitogen-activated protein kinase kinase kinase 9 |
| chr11_+_44587206 | 7.61 |
ENST00000525210.1
ENST00000527737.1 ENST00000524704.1 |
CD82
|
CD82 molecule |
| chr12_+_100660909 | 7.57 |
ENST00000549687.1
|
SCYL2
|
SCY1-like 2 (S. cerevisiae) |
| chr6_-_30523865 | 7.57 |
ENST00000433809.1
|
GNL1
|
guanine nucleotide binding protein-like 1 |
| chr1_-_153588334 | 7.57 |
ENST00000476873.1
|
S100A14
|
S100 calcium binding protein A14 |
| chr1_+_209602156 | 7.56 |
ENST00000429156.1
ENST00000366437.3 ENST00000603283.1 ENST00000431096.1 |
MIR205HG
|
MIR205 host gene (non-protein coding) |
| chr12_-_50677255 | 7.54 |
ENST00000551691.1
ENST00000394943.3 ENST00000341247.4 |
LIMA1
|
LIM domain and actin binding 1 |
| chr6_-_35464727 | 7.53 |
ENST00000402886.3
|
TEAD3
|
TEA domain family member 3 |
| chr22_+_31608219 | 7.53 |
ENST00000406516.1
ENST00000444929.2 ENST00000331728.4 |
LIMK2
|
LIM domain kinase 2 |
| chr1_-_202936394 | 7.52 |
ENST00000367249.4
|
CYB5R1
|
cytochrome b5 reductase 1 |
| chr2_-_242255060 | 7.51 |
ENST00000413241.1
ENST00000423693.1 ENST00000428482.1 |
HDLBP
|
high density lipoprotein binding protein |
| chr3_-_52312337 | 7.44 |
ENST00000469000.1
|
WDR82
|
WD repeat domain 82 |
| chr4_+_106816592 | 7.43 |
ENST00000379987.2
ENST00000453617.2 ENST00000427316.2 ENST00000514622.1 ENST00000305572.8 |
NPNT
|
nephronectin |
| chr1_-_23670752 | 7.42 |
ENST00000302271.6
ENST00000426846.2 ENST00000427764.2 ENST00000606561.1 ENST00000374616.3 |
HNRNPR
|
heterogeneous nuclear ribonucleoprotein R |
| chr7_-_143105941 | 7.36 |
ENST00000275815.3
|
EPHA1
|
EPH receptor A1 |
| chr19_-_51487071 | 7.36 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
| chr7_-_105029329 | 7.36 |
ENST00000393651.3
ENST00000460391.1 |
SRPK2
|
SRSF protein kinase 2 |
| chr2_+_238600933 | 7.31 |
ENST00000420665.1
ENST00000392000.4 |
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
| chr15_+_98503922 | 7.29 |
ENST00000268042.6
|
ARRDC4
|
arrestin domain containing 4 |
| chr15_+_41136369 | 7.26 |
ENST00000563656.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr2_+_70142189 | 7.25 |
ENST00000264444.2
|
MXD1
|
MAX dimerization protein 1 |
| chr12_-_33049690 | 7.20 |
ENST00000070846.6
ENST00000340811.4 |
PKP2
|
plakophilin 2 |
| chr2_+_10091783 | 7.20 |
ENST00000324883.5
|
GRHL1
|
grainyhead-like 1 (Drosophila) |
| chr14_+_59655369 | 7.20 |
ENST00000360909.3
ENST00000351081.1 ENST00000556135.1 |
DAAM1
|
dishevelled associated activator of morphogenesis 1 |
| chr1_-_23495303 | 7.20 |
ENST00000314174.5
ENST00000471849.1 |
LUZP1
|
leucine zipper protein 1 |
| chr4_-_125633876 | 7.19 |
ENST00000504087.1
ENST00000515641.1 |
ANKRD50
|
ankyrin repeat domain 50 |
| chr3_-_176914998 | 7.17 |
ENST00000431421.1
ENST00000422066.1 ENST00000413084.1 |
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1 |
| chr1_+_68150744 | 7.15 |
ENST00000370986.4
ENST00000370985.3 |
GADD45A
|
growth arrest and DNA-damage-inducible, alpha |
| chr3_+_50273625 | 7.12 |
ENST00000536647.1
|
GNAI2
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
| chr3_-_52090461 | 7.11 |
ENST00000296483.6
ENST00000495880.1 |
DUSP7
|
dual specificity phosphatase 7 |
| chr3_+_184032313 | 7.09 |
ENST00000392537.2
ENST00000444134.1 ENST00000450424.1 ENST00000421110.1 ENST00000382330.3 ENST00000426123.1 ENST00000350481.5 ENST00000455679.1 ENST00000440448.1 |
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1 |
| chr1_+_154193643 | 7.07 |
ENST00000456325.1
|
UBAP2L
|
ubiquitin associated protein 2-like |
| chr22_+_38035623 | 7.07 |
ENST00000336738.5
ENST00000442465.2 |
SH3BP1
|
SH3-domain binding protein 1 |
| chr8_+_94929273 | 7.06 |
ENST00000518573.1
|
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
| chr1_+_116915270 | 7.03 |
ENST00000418797.1
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
| chr5_+_9546376 | 7.01 |
ENST00000509788.1
|
SNHG18
|
small nucleolar RNA host gene 18 (non-protein coding) |
| chr2_+_148778570 | 7.01 |
ENST00000407073.1
|
MBD5
|
methyl-CpG binding domain protein 5 |
| chr12_-_93323013 | 6.99 |
ENST00000322349.8
|
EEA1
|
early endosome antigen 1 |
| chrX_+_18443703 | 6.98 |
ENST00000379996.3
|
CDKL5
|
cyclin-dependent kinase-like 5 |
| chr1_+_112939121 | 6.95 |
ENST00000441739.1
|
CTTNBP2NL
|
CTTNBP2 N-terminal like |
| chr17_+_36584662 | 6.93 |
ENST00000431231.2
ENST00000437668.3 |
ARHGAP23
|
Rho GTPase activating protein 23 |
| chr8_+_94929168 | 6.92 |
ENST00000518107.1
ENST00000396200.3 |
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
| chr6_-_112194484 | 6.88 |
ENST00000518295.1
ENST00000484067.2 ENST00000229470.5 ENST00000356013.2 ENST00000368678.4 ENST00000523238.1 ENST00000354650.3 |
FYN
|
FYN oncogene related to SRC, FGR, YES |
| chr11_-_64612041 | 6.85 |
ENST00000342711.5
|
CDC42BPG
|
CDC42 binding protein kinase gamma (DMPK-like) |
| chr1_+_10093188 | 6.85 |
ENST00000377153.1
|
UBE4B
|
ubiquitination factor E4B |
| chr22_+_41777927 | 6.85 |
ENST00000266304.4
|
TEF
|
thyrotrophic embryonic factor |
| chr19_+_45754505 | 6.83 |
ENST00000262891.4
ENST00000300843.4 |
MARK4
|
MAP/microtubule affinity-regulating kinase 4 |
| chr7_+_143318020 | 6.82 |
ENST00000444908.2
ENST00000518791.1 ENST00000411497.2 |
FAM115C
|
family with sequence similarity 115, member C |
| chr6_+_37787704 | 6.82 |
ENST00000474522.1
|
ZFAND3
|
zinc finger, AN1-type domain 3 |
| chr6_+_4776580 | 6.75 |
ENST00000397588.3
|
CDYL
|
chromodomain protein, Y-like |
| chr1_-_22263790 | 6.75 |
ENST00000374695.3
|
HSPG2
|
heparan sulfate proteoglycan 2 |
| chr1_-_9970383 | 6.72 |
ENST00000400904.3
|
CTNNBIP1
|
catenin, beta interacting protein 1 |
| chr1_+_112938803 | 6.70 |
ENST00000271277.6
|
CTTNBP2NL
|
CTTNBP2 N-terminal like |
| chr10_-_12084770 | 6.69 |
ENST00000357604.5
|
UPF2
|
UPF2 regulator of nonsense transcripts homolog (yeast) |
| chr12_+_57522258 | 6.67 |
ENST00000553277.1
ENST00000243077.3 |
LRP1
|
low density lipoprotein receptor-related protein 1 |
| chr22_+_38035459 | 6.64 |
ENST00000357436.4
|
SH3BP1
|
SH3-domain binding protein 1 |
| chr8_+_94929110 | 6.64 |
ENST00000520728.1
|
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
| chr8_+_94929077 | 6.64 |
ENST00000297598.4
ENST00000520614.1 |
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
| chr10_-_25012115 | 6.60 |
ENST00000446003.1
|
ARHGAP21
|
Rho GTPase activating protein 21 |
| chr21_-_40720995 | 6.59 |
ENST00000380749.5
|
HMGN1
|
high mobility group nucleosome binding domain 1 |
| chr3_-_48130314 | 6.59 |
ENST00000439356.1
ENST00000395734.3 ENST00000426837.2 |
MAP4
|
microtubule-associated protein 4 |
| chr2_+_192543153 | 6.58 |
ENST00000425611.2
|
NABP1
|
nucleic acid binding protein 1 |
| chr20_-_40247133 | 6.56 |
ENST00000373233.3
ENST00000309279.7 |
CHD6
|
chromodomain helicase DNA binding protein 6 |
| chr10_+_76586348 | 6.52 |
ENST00000372724.1
ENST00000287239.4 ENST00000372714.1 |
KAT6B
|
K(lysine) acetyltransferase 6B |
| chr12_+_107349606 | 6.52 |
ENST00000547242.1
ENST00000551489.1 ENST00000550344.1 |
C12orf23
|
chromosome 12 open reading frame 23 |
| chr18_+_61143994 | 6.52 |
ENST00000382771.4
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
| chr1_+_33219592 | 6.50 |
ENST00000373481.3
|
KIAA1522
|
KIAA1522 |
| chr17_-_7164410 | 6.50 |
ENST00000574070.1
|
CLDN7
|
claudin 7 |
| chr3_+_40428647 | 6.47 |
ENST00000301825.3
ENST00000439533.1 ENST00000456402.1 |
ENTPD3
|
ectonucleoside triphosphate diphosphohydrolase 3 |
| chr21_+_27107672 | 6.47 |
ENST00000400075.3
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa |
| chr2_+_173292280 | 6.44 |
ENST00000264107.7
|
ITGA6
|
integrin, alpha 6 |
| chr12_+_57522439 | 6.43 |
ENST00000338962.4
|
LRP1
|
low density lipoprotein receptor-related protein 1 |
| chr17_+_7348658 | 6.43 |
ENST00000570557.1
ENST00000536404.2 ENST00000576360.1 |
CHRNB1
|
cholinergic receptor, nicotinic, beta 1 (muscle) |
| chr1_+_65886244 | 6.37 |
ENST00000344610.8
|
LEPR
|
leptin receptor |
| chr19_+_45281118 | 6.36 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
| chr22_+_29469100 | 6.34 |
ENST00000327813.5
ENST00000407188.1 |
KREMEN1
|
kringle containing transmembrane protein 1 |
| chr21_+_37692481 | 6.28 |
ENST00000400485.1
|
MORC3
|
MORC family CW-type zinc finger 3 |
| chr12_-_54785074 | 6.27 |
ENST00000338010.5
ENST00000550774.1 |
ZNF385A
|
zinc finger protein 385A |
| chr7_-_129592471 | 6.26 |
ENST00000473814.2
ENST00000490974.1 |
UBE2H
|
ubiquitin-conjugating enzyme E2H |
| chr19_-_12912657 | 6.25 |
ENST00000301522.2
|
PRDX2
|
peroxiredoxin 2 |
| chr1_-_113258090 | 6.24 |
ENST00000309276.6
|
PPM1J
|
protein phosphatase, Mg2+/Mn2+ dependent, 1J |
| chr6_-_31846744 | 6.24 |
ENST00000414427.1
ENST00000229729.6 ENST00000375562.4 |
SLC44A4
|
solute carrier family 44, member 4 |
| chr17_+_29815013 | 6.23 |
ENST00000394744.2
|
RAB11FIP4
|
RAB11 family interacting protein 4 (class II) |
| chr1_-_182360918 | 6.23 |
ENST00000339526.4
|
GLUL
|
glutamate-ammonia ligase |
| chr1_+_40506255 | 6.22 |
ENST00000421589.1
|
CAP1
|
CAP, adenylate cyclase-associated protein 1 (yeast) |
| chr2_+_242254753 | 6.21 |
ENST00000428524.1
ENST00000445030.1 ENST00000407017.1 |
SEPT2
|
septin 2 |
| chr16_+_50775971 | 6.21 |
ENST00000311559.9
ENST00000564326.1 ENST00000566206.1 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
| chr9_-_139440314 | 6.20 |
ENST00000277541.6
|
NOTCH1
|
notch 1 |
| chr13_-_20767037 | 6.19 |
ENST00000382848.4
|
GJB2
|
gap junction protein, beta 2, 26kDa |
| chr1_+_230203010 | 6.17 |
ENST00000541865.1
|
GALNT2
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
| chr1_+_150254936 | 6.17 |
ENST00000447007.1
ENST00000369095.1 ENST00000369094.1 |
C1orf51
|
chromosome 1 open reading frame 51 |
| chr1_-_95007193 | 6.16 |
ENST00000370207.4
ENST00000334047.7 |
F3
|
coagulation factor III (thromboplastin, tissue factor) |
| chr22_+_41487711 | 6.16 |
ENST00000263253.7
|
EP300
|
E1A binding protein p300 |
| chr22_+_30792980 | 6.15 |
ENST00000403484.1
ENST00000405717.3 ENST00000402592.3 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
| chr19_-_2151523 | 6.14 |
ENST00000350812.6
ENST00000355272.6 ENST00000356926.4 ENST00000345016.5 |
AP3D1
|
adaptor-related protein complex 3, delta 1 subunit |
| chr19_+_39687596 | 6.13 |
ENST00000339852.4
|
NCCRP1
|
non-specific cytotoxic cell receptor protein 1 homolog (zebrafish) |
Network of associatons between targets according to the STRING database.
First level regulatory network of SP1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.8 | 27.1 | GO:0051796 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 5.6 | 22.4 | GO:0003169 | coronary vein morphogenesis(GO:0003169) |
| 5.4 | 16.1 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 5.3 | 21.3 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 5.3 | 5.3 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
| 4.9 | 14.6 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 4.7 | 14.2 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 4.6 | 22.8 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 4.3 | 12.9 | GO:0008052 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 4.3 | 59.9 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 4.1 | 4.1 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
| 4.1 | 20.6 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 3.9 | 15.8 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 3.9 | 19.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 3.6 | 14.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 3.5 | 20.8 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 3.5 | 3.5 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 3.4 | 3.4 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 3.4 | 10.1 | GO:0021503 | neural fold bending(GO:0021503) |
| 3.4 | 20.1 | GO:0030421 | defecation(GO:0030421) |
| 3.3 | 13.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 3.3 | 19.7 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 3.2 | 13.0 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
| 3.2 | 9.6 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 3.1 | 9.4 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
| 3.1 | 12.4 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
| 3.1 | 9.2 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 3.0 | 30.5 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 3.0 | 9.1 | GO:0048627 | myoblast development(GO:0048627) |
| 3.0 | 9.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 3.0 | 12.0 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 3.0 | 6.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 2.9 | 8.7 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 2.9 | 2.9 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 2.8 | 8.5 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 2.8 | 11.4 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 2.8 | 11.2 | GO:1904501 | glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 2.8 | 8.3 | GO:1903515 | calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 2.8 | 11.1 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
| 2.8 | 2.8 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 2.7 | 13.5 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 2.6 | 23.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 2.6 | 23.3 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
| 2.6 | 28.2 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
| 2.5 | 32.2 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 2.4 | 7.3 | GO:1903249 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 2.4 | 11.9 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 2.4 | 7.1 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 2.4 | 2.4 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 2.3 | 9.4 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 2.3 | 16.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 2.3 | 6.9 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 2.3 | 6.9 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
| 2.3 | 6.9 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 2.3 | 13.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 2.3 | 33.9 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 2.2 | 17.9 | GO:0048102 | autophagic cell death(GO:0048102) |
| 2.2 | 15.7 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 2.2 | 2.2 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 2.2 | 6.7 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 2.2 | 8.8 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 2.2 | 33.0 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 2.2 | 10.9 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 2.2 | 6.5 | GO:1990709 | presynaptic active zone organization(GO:1990709) |
| 2.2 | 6.5 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 2.1 | 15.0 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 2.1 | 2.1 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
| 2.1 | 16.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 2.1 | 6.3 | GO:1904351 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 2.1 | 2.1 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
| 2.1 | 12.5 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 2.1 | 6.2 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 2.1 | 10.3 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 2.1 | 8.2 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 2.1 | 6.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 2.0 | 30.6 | GO:0060613 | fat pad development(GO:0060613) |
| 2.0 | 10.2 | GO:0021623 | optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 2.0 | 10.1 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 2.0 | 14.2 | GO:0051012 | microtubule sliding(GO:0051012) |
| 2.0 | 32.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 2.0 | 6.1 | GO:0034147 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 2.0 | 6.0 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
| 2.0 | 4.0 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 2.0 | 6.0 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 2.0 | 6.0 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 2.0 | 7.9 | GO:0090095 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 2.0 | 7.8 | GO:0009956 | radial pattern formation(GO:0009956) |
| 1.9 | 11.7 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 1.9 | 5.8 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 1.9 | 7.7 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 1.9 | 3.8 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 1.9 | 7.6 | GO:1904800 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 1.9 | 5.7 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 1.9 | 15.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 1.9 | 7.5 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 1.9 | 13.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 1.8 | 9.2 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 1.8 | 7.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 1.8 | 3.7 | GO:0009216 | purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) |
| 1.8 | 5.4 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 1.8 | 10.7 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
| 1.8 | 8.9 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 1.8 | 5.3 | GO:0042938 | dipeptide transport(GO:0042938) |
| 1.8 | 28.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 1.7 | 1.7 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
| 1.7 | 32.6 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 1.7 | 6.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 1.7 | 10.1 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 1.7 | 23.5 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 1.7 | 1.7 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 1.7 | 6.7 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 1.7 | 10.0 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 1.7 | 11.6 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
| 1.7 | 1.7 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 1.7 | 5.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.7 | 5.0 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 1.6 | 16.4 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 1.6 | 9.8 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 1.6 | 17.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 1.6 | 1.6 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
| 1.6 | 9.6 | GO:0042335 | cuticle development(GO:0042335) |
| 1.6 | 6.4 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 1.6 | 4.8 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.6 | 27.1 | GO:0015871 | choline transport(GO:0015871) |
| 1.6 | 4.8 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 1.6 | 36.3 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 1.6 | 11.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 1.6 | 1.6 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
| 1.6 | 17.2 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 1.6 | 23.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 1.6 | 9.3 | GO:0070384 | Harderian gland development(GO:0070384) |
| 1.5 | 1.5 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 1.5 | 3.1 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 1.5 | 4.6 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 1.5 | 9.2 | GO:0070417 | cellular response to cold(GO:0070417) |
| 1.5 | 12.3 | GO:0002934 | desmosome organization(GO:0002934) |
| 1.5 | 6.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 1.5 | 9.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 1.5 | 3.0 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 1.5 | 1.5 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 1.5 | 42.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 1.5 | 4.5 | GO:0051258 | protein polymerization(GO:0051258) |
| 1.5 | 10.6 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 1.5 | 6.0 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 1.5 | 1.5 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 1.5 | 3.0 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 1.5 | 17.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 1.5 | 17.7 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 1.5 | 4.4 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
| 1.5 | 1.5 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 1.5 | 5.9 | GO:0051413 | response to cortisone(GO:0051413) |
| 1.5 | 13.2 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 1.5 | 7.3 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 1.5 | 1.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 1.5 | 37.9 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 1.5 | 1.5 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 1.5 | 4.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 1.5 | 5.8 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 1.4 | 1.4 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 1.4 | 7.2 | GO:1902904 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 1.4 | 2.9 | GO:0061145 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
| 1.4 | 1.4 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
| 1.4 | 14.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 1.4 | 4.2 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 1.4 | 4.2 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 1.4 | 1.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 1.4 | 11.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 1.4 | 2.8 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 1.4 | 4.1 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 1.4 | 13.7 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 1.4 | 4.1 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 1.3 | 4.0 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 1.3 | 2.7 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
| 1.3 | 4.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 1.3 | 4.0 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 1.3 | 17.2 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
| 1.3 | 4.0 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 1.3 | 22.4 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 1.3 | 5.2 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 1.3 | 3.9 | GO:0001300 | chronological cell aging(GO:0001300) |
| 1.3 | 18.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 1.3 | 1.3 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 1.3 | 1.3 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 1.3 | 5.1 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 1.3 | 3.8 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 1.3 | 5.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 1.3 | 2.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 1.3 | 5.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 1.3 | 3.8 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 1.3 | 3.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 1.2 | 10.0 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 1.2 | 6.2 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 1.2 | 3.7 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 1.2 | 7.4 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 1.2 | 1.2 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
| 1.2 | 4.9 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 1.2 | 1.2 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 1.2 | 6.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 1.2 | 8.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 1.2 | 6.1 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 1.2 | 8.4 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
| 1.2 | 2.4 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 1.2 | 2.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 1.2 | 8.4 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 1.2 | 3.6 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 1.2 | 4.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 1.2 | 3.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 1.2 | 4.7 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 1.2 | 7.0 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 1.2 | 1.2 | GO:0007051 | spindle organization(GO:0007051) |
| 1.2 | 4.7 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 1.2 | 3.5 | GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 1.2 | 5.8 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 1.2 | 9.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 1.2 | 22.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 1.2 | 2.3 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 1.2 | 6.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.1 | 9.2 | GO:0003383 | apical constriction(GO:0003383) |
| 1.1 | 4.5 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 1.1 | 20.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 1.1 | 7.9 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 1.1 | 30.5 | GO:0051639 | actin filament network formation(GO:0051639) |
| 1.1 | 5.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 1.1 | 3.4 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 1.1 | 2.2 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
| 1.1 | 12.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 1.1 | 5.5 | GO:0032796 | uropod organization(GO:0032796) |
| 1.1 | 5.5 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 1.1 | 1.1 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 1.1 | 2.2 | GO:0018065 | protein lipoylation(GO:0009249) protein-cofactor linkage(GO:0018065) |
| 1.1 | 7.6 | GO:0046836 | glycolipid transport(GO:0046836) |
| 1.1 | 3.3 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 1.1 | 6.5 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
| 1.1 | 3.3 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 1.1 | 27.0 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 1.1 | 20.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 1.1 | 6.5 | GO:0030578 | PML body organization(GO:0030578) |
| 1.1 | 3.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 1.1 | 11.8 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 1.1 | 3.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 1.1 | 7.5 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 1.1 | 5.3 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 1.1 | 3.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
| 1.1 | 4.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
| 1.1 | 2.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 1.1 | 7.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 1.1 | 3.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 1.0 | 3.1 | GO:1904237 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 1.0 | 1.0 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 1.0 | 4.1 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 1.0 | 4.1 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 1.0 | 1.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 1.0 | 11.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 1.0 | 14.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 1.0 | 9.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 1.0 | 5.1 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 1.0 | 7.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 1.0 | 8.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 1.0 | 8.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 1.0 | 4.0 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 1.0 | 5.0 | GO:0051622 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 1.0 | 2.0 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 1.0 | 18.1 | GO:0015816 | glycine transport(GO:0015816) |
| 1.0 | 6.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 1.0 | 23.8 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 1.0 | 6.9 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 1.0 | 17.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 1.0 | 2.0 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 1.0 | 4.9 | GO:0030035 | microspike assembly(GO:0030035) |
| 1.0 | 1.0 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
| 1.0 | 8.9 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 1.0 | 11.8 | GO:0021759 | globus pallidus development(GO:0021759) |
| 1.0 | 2.0 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 1.0 | 2.9 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 1.0 | 5.9 | GO:0007032 | endosome organization(GO:0007032) |
| 1.0 | 26.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 1.0 | 8.7 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 1.0 | 7.7 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 1.0 | 1.0 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 1.0 | 3.8 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 1.0 | 4.8 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 1.0 | 4.8 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.9 | 2.8 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
| 0.9 | 4.7 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.9 | 13.3 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.9 | 2.8 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.9 | 1.9 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.9 | 0.9 | GO:0060119 | inner ear receptor cell development(GO:0060119) inner ear receptor stereocilium organization(GO:0060122) |
| 0.9 | 19.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.9 | 2.8 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.9 | 4.6 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 0.9 | 2.8 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.9 | 3.7 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.9 | 4.6 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.9 | 8.3 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.9 | 8.3 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.9 | 3.7 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.9 | 6.4 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.9 | 0.9 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.9 | 5.5 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.9 | 7.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.9 | 7.2 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.9 | 11.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.9 | 2.7 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.9 | 1.8 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
| 0.9 | 8.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.9 | 4.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.9 | 1.8 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.9 | 5.3 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.9 | 17.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.9 | 1.8 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.9 | 4.4 | GO:0061528 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.9 | 4.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.9 | 17.6 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.9 | 2.6 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.9 | 6.2 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 0.9 | 32.5 | GO:0060674 | placenta blood vessel development(GO:0060674) |
| 0.9 | 9.6 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.9 | 1.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
| 0.9 | 7.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.9 | 2.6 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.9 | 6.0 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.9 | 3.4 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.9 | 2.6 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.9 | 1.7 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 0.9 | 3.4 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.8 | 0.8 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
| 0.8 | 5.1 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.8 | 2.5 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.8 | 3.3 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.8 | 5.0 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.8 | 2.5 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.8 | 3.3 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.8 | 1.7 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.8 | 2.5 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.8 | 2.5 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.8 | 0.8 | GO:0045103 | intermediate filament-based process(GO:0045103) |
| 0.8 | 1.6 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.8 | 1.6 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.8 | 4.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.8 | 2.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.8 | 2.4 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.8 | 16.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.8 | 0.8 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.8 | 3.2 | GO:1903332 | regulation of protein folding(GO:1903332) |
| 0.8 | 3.2 | GO:1904796 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.8 | 4.0 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.8 | 4.0 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.8 | 17.6 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.8 | 6.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.8 | 24.6 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.8 | 4.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.8 | 4.7 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.8 | 15.0 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.8 | 3.1 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.8 | 8.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.8 | 5.5 | GO:0002327 | immature B cell differentiation(GO:0002327) |
| 0.8 | 13.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.8 | 0.8 | GO:1901205 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 0.8 | 6.2 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
| 0.8 | 10.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.8 | 7.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.8 | 4.6 | GO:1901911 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.8 | 3.1 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.8 | 2.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.8 | 8.4 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.8 | 1.5 | GO:2000452 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.8 | 2.3 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.8 | 9.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.8 | 1.5 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 0.8 | 0.8 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.8 | 6.0 | GO:0048298 | regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.8 | 3.8 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.8 | 2.3 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.7 | 3.0 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.7 | 2.2 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
| 0.7 | 1.5 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.7 | 1.5 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.7 | 3.7 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.7 | 2.2 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 0.7 | 0.7 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.7 | 2.2 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.7 | 11.8 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.7 | 3.7 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.7 | 2.9 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.7 | 2.2 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) negative regulation of store-operated calcium channel activity(GO:1901340) |
| 0.7 | 3.7 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.7 | 2.9 | GO:0008354 | germ cell migration(GO:0008354) |
| 0.7 | 12.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.7 | 8.0 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.7 | 2.2 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.7 | 10.8 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.7 | 8.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.7 | 10.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.7 | 1.4 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
| 0.7 | 2.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.7 | 2.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.7 | 2.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.7 | 0.7 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 0.7 | 6.4 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.7 | 4.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.7 | 6.4 | GO:0035733 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
| 0.7 | 2.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.7 | 2.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.7 | 2.1 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.7 | 2.1 | GO:0070377 | regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.7 | 0.7 | GO:1903051 | negative regulation of proteolysis involved in cellular protein catabolic process(GO:1903051) |
| 0.7 | 7.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.7 | 2.1 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.7 | 7.7 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.7 | 2.8 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.7 | 22.3 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.7 | 2.1 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.7 | 4.8 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
| 0.7 | 2.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.7 | 9.7 | GO:0060013 | righting reflex(GO:0060013) |
| 0.7 | 1.4 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.7 | 19.2 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.7 | 1.4 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.7 | 16.4 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.7 | 2.7 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.7 | 0.7 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
| 0.7 | 2.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.7 | 6.1 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.7 | 14.3 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.7 | 2.7 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
| 0.7 | 3.4 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.7 | 17.6 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
| 0.7 | 6.7 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.7 | 9.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.7 | 6.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.7 | 7.3 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.7 | 1.3 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.7 | 11.3 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.7 | 6.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.7 | 17.9 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.7 | 7.9 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.7 | 0.7 | GO:0034331 | cell junction maintenance(GO:0034331) |
| 0.7 | 2.0 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.7 | 2.6 | GO:0097192 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
| 0.7 | 9.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.7 | 2.0 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 0.6 | 1.9 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.6 | 3.9 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
| 0.6 | 0.6 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.6 | 1.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.6 | 41.0 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.6 | 4.5 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.6 | 0.6 | GO:0048747 | muscle fiber development(GO:0048747) |
| 0.6 | 14.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.6 | 1.3 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.6 | 5.8 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.6 | 2.5 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.6 | 11.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
| 0.6 | 3.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.6 | 1.9 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.6 | 3.2 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.6 | 7.0 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.6 | 2.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.6 | 15.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.6 | 0.6 | GO:1903170 | negative regulation of calcium ion transmembrane transport(GO:1903170) |
| 0.6 | 2.5 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.6 | 14.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.6 | 1.9 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.6 | 4.9 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.6 | 4.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.6 | 0.6 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.6 | 8.0 | GO:0060004 | reflex(GO:0060004) |
| 0.6 | 1.8 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.6 | 5.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.6 | 7.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.6 | 7.3 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.6 | 2.4 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.6 | 2.4 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.6 | 3.0 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 0.6 | 1.8 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.6 | 1.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.6 | 5.4 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.6 | 1.2 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.6 | 4.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.6 | 17.8 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 0.6 | 1.2 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.6 | 8.3 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.6 | 4.1 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.6 | 17.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.6 | 1.8 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
| 0.6 | 5.9 | GO:0060717 | chorion development(GO:0060717) |
| 0.6 | 6.4 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.6 | 1.8 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.6 | 6.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.6 | 2.9 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.6 | 1.7 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.6 | 1.7 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.6 | 2.9 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.6 | 5.8 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.6 | 4.0 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.6 | 1.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.6 | 0.6 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.6 | 2.3 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
| 0.6 | 1.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.6 | 2.3 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.6 | 5.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.6 | 7.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.6 | 7.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.6 | 4.0 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.6 | 6.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.6 | 10.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.6 | 10.0 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.6 | 2.2 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.6 | 3.3 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
| 0.6 | 3.3 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.6 | 1.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
| 0.6 | 1.7 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.6 | 1.7 | GO:2000742 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.5 | 0.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.5 | 3.3 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.5 | 6.0 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.5 | 1.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.5 | 0.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.5 | 1.1 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.5 | 1.1 | GO:0046730 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.5 | 4.3 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.5 | 3.2 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.5 | 5.4 | GO:0019405 | alditol catabolic process(GO:0019405) |
| 0.5 | 9.6 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
| 0.5 | 3.7 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.5 | 13.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.5 | 0.5 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
| 0.5 | 1.6 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 0.5 | 1.1 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.5 | 11.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.5 | 3.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.5 | 1.6 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.5 | 11.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.5 | 3.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.5 | 0.5 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
| 0.5 | 5.3 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
| 0.5 | 1.6 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.5 | 1.0 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
| 0.5 | 4.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.5 | 6.8 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.5 | 3.6 | GO:0009188 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.5 | 3.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.5 | 1.0 | GO:0070781 | response to biotin(GO:0070781) |
| 0.5 | 2.6 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.5 | 4.1 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
| 0.5 | 4.1 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.5 | 1.5 | GO:0042245 | RNA repair(GO:0042245) |
| 0.5 | 0.5 | GO:0060993 | kidney morphogenesis(GO:0060993) |
| 0.5 | 0.5 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.5 | 3.1 | GO:0030047 | actin modification(GO:0030047) |
| 0.5 | 0.5 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.5 | 0.5 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
| 0.5 | 1.0 | GO:0033622 | integrin activation(GO:0033622) |
| 0.5 | 1.5 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.5 | 3.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.5 | 2.5 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 0.5 | 7.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.5 | 19.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.5 | 15.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.5 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.5 | 3.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.5 | 3.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.5 | 3.0 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.5 | 4.5 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.5 | 3.0 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.5 | 0.5 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
| 0.5 | 8.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.5 | 3.4 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.5 | 1.5 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.5 | 1.5 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.5 | 3.9 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.5 | 2.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.5 | 7.8 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.5 | 5.8 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.5 | 1.5 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.5 | 13.5 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.5 | 2.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.5 | 3.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.5 | 1.4 | GO:0071514 | genetic imprinting(GO:0071514) |
| 0.5 | 6.6 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.5 | 0.9 | GO:0032763 | mast cell cytokine production(GO:0032762) regulation of mast cell cytokine production(GO:0032763) negative regulation of mast cell cytokine production(GO:0032764) |
| 0.5 | 4.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.5 | 8.0 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.5 | 1.9 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.5 | 1.9 | GO:1990834 | response to odorant(GO:1990834) |
| 0.5 | 5.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.5 | 0.9 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.5 | 1.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.5 | 3.3 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.5 | 2.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
| 0.5 | 3.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.5 | 2.3 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.5 | 0.5 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.5 | 17.4 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.5 | 3.7 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
| 0.5 | 1.4 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.5 | 3.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.5 | 3.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.5 | 2.7 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.5 | 2.7 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.4 | 7.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.4 | 6.3 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.4 | 16.0 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.4 | 6.6 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.4 | 2.7 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.4 | 5.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.4 | 1.7 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.4 | 21.3 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.4 | 0.9 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.4 | 1.3 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
| 0.4 | 1.3 | GO:0071790 | spindle pole body duplication(GO:0030474) nuclear pore distribution(GO:0031081) spindle pole body organization(GO:0051300) nuclear pore localization(GO:0051664) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.4 | 14.3 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
| 0.4 | 3.5 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.4 | 2.6 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.4 | 0.9 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.4 | 4.7 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.4 | 3.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.4 | 3.4 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.4 | 1.7 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.4 | 1.7 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
| 0.4 | 1.7 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.4 | 1.3 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.4 | 3.8 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
| 0.4 | 0.8 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.4 | 4.6 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 0.4 | 8.8 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.4 | 3.7 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.4 | 10.0 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.4 | 1.2 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.4 | 4.6 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.4 | 0.4 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.4 | 1.7 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.4 | 2.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.4 | 6.2 | GO:0007614 | short-term memory(GO:0007614) |
| 0.4 | 2.9 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 0.4 | 12.2 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.4 | 4.5 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 0.4 | 0.8 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.4 | 5.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.4 | 1.6 | GO:0070895 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 0.4 | 27.1 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
| 0.4 | 2.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.4 | 2.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.4 | 1.2 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.4 | 3.6 | GO:0006939 | smooth muscle contraction(GO:0006939) |
| 0.4 | 12.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.4 | 2.0 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
| 0.4 | 0.4 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
| 0.4 | 1.6 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.4 | 2.4 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.4 | 2.0 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.4 | 2.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.4 | 1.6 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.4 | 1.9 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.4 | 2.3 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.4 | 4.3 | GO:0070141 | response to UV-A(GO:0070141) |
| 0.4 | 1.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.4 | 2.7 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.4 | 13.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.4 | 2.3 | GO:0060180 | female mating behavior(GO:0060180) |
| 0.4 | 4.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.4 | 3.1 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.4 | 2.3 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.4 | 4.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.4 | 1.1 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.4 | 3.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.4 | 4.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.4 | 0.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.4 | 4.1 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
| 0.4 | 1.5 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 0.4 | 1.1 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.4 | 2.6 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.4 | 0.4 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 0.4 | 5.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.4 | 1.5 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.4 | 0.4 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.4 | 4.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.4 | 2.9 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.4 | 4.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.4 | 0.7 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
| 0.4 | 2.9 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
| 0.4 | 0.7 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
| 0.4 | 9.9 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.4 | 2.2 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.4 | 3.7 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.4 | 3.3 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.4 | 6.6 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.4 | 1.1 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.4 | 1.1 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.4 | 1.1 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
| 0.4 | 4.7 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.4 | 2.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.4 | 4.0 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.4 | 2.2 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.4 | 1.1 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.4 | 3.6 | GO:0031114 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
| 0.4 | 0.7 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.4 | 1.1 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.4 | 1.4 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.4 | 1.8 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.4 | 0.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.4 | 11.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.4 | 2.1 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.4 | 3.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.4 | 2.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.4 | 1.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.4 | 1.8 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.4 | 1.4 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.4 | 1.8 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.4 | 0.7 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.4 | 1.8 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
| 0.3 | 0.3 | GO:1904868 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.3 | 0.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.3 | 0.7 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
| 0.3 | 4.8 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.3 | 0.7 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
| 0.3 | 6.9 | GO:0010390 | histone monoubiquitination(GO:0010390) |
| 0.3 | 2.7 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.3 | 2.4 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.3 | 1.0 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.3 | 9.2 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.3 | 33.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.3 | 1.0 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.3 | 6.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.3 | 3.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.3 | 3.7 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.3 | 2.0 | GO:0060992 | response to fungicide(GO:0060992) |
| 0.3 | 1.3 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.3 | 7.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.3 | 2.3 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.3 | 1.7 | GO:0007608 | sensory perception of smell(GO:0007608) |
| 0.3 | 3.0 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.3 | 0.3 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.3 | 1.3 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.3 | 0.7 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) positive regulation of Schwann cell differentiation(GO:0014040) |
| 0.3 | 1.3 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) succinyl-CoA pathway(GO:0006781) uroporphyrinogen III metabolic process(GO:0046502) |
| 0.3 | 3.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.3 | 3.6 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.3 | 4.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.3 | 2.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.3 | 2.6 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.3 | 4.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.3 | 2.3 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.3 | 8.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.3 | 5.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.3 | 1.9 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.3 | 0.6 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.3 | 1.3 | GO:0050992 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.3 | 2.9 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.3 | 1.3 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.3 | 6.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.3 | 3.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.3 | 2.6 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.3 | 1.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.3 | 1.9 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.3 | 0.3 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) |
| 0.3 | 0.3 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.3 | 1.3 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.3 | 1.9 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.3 | 0.6 | GO:0015883 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.3 | 2.5 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.3 | 0.6 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.3 | 0.3 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.3 | 1.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.3 | 38.7 | GO:0070268 | cornification(GO:0070268) |
| 0.3 | 0.3 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.3 | 3.7 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
| 0.3 | 19.2 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.3 | 2.7 | GO:0021987 | cerebral cortex development(GO:0021987) |
| 0.3 | 0.6 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.3 | 4.3 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
| 0.3 | 2.4 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.3 | 0.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 | 1.2 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.3 | 0.6 | GO:0021761 | limbic system development(GO:0021761) |
| 0.3 | 1.2 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.3 | 2.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.3 | 3.0 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.3 | 1.2 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.3 | 6.0 | GO:0031498 | chromatin disassembly(GO:0031498) |
| 0.3 | 4.2 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.3 | 12.8 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
| 0.3 | 3.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.3 | 0.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.3 | 1.8 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.3 | 1.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.3 | 49.8 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.3 | 2.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.3 | 1.2 | GO:0032328 | alanine transport(GO:0032328) |
| 0.3 | 2.6 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.3 | 2.1 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.3 | 2.0 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.3 | 2.9 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.3 | 1.2 | GO:0032402 | melanosome localization(GO:0032400) establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) |
| 0.3 | 2.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.3 | 1.5 | GO:1905245 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.3 | 1.4 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.3 | 1.4 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
| 0.3 | 4.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.3 | 1.1 | GO:0042113 | B cell activation(GO:0042113) |
| 0.3 | 1.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.3 | 1.7 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.3 | 3.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.3 | 5.7 | GO:0046546 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.3 | 3.1 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.3 | 1.4 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.3 | 1.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.3 | 21.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.3 | 2.8 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.3 | 2.8 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 0.3 | 4.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.3 | 1.1 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.3 | 0.8 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
| 0.3 | 1.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.3 | 15.3 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
| 0.3 | 0.8 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.3 | 8.3 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.3 | 0.8 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.3 | 0.3 | GO:0051584 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
| 0.3 | 2.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.3 | 0.5 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 0.3 | 2.2 | GO:0015074 | DNA integration(GO:0015074) |
| 0.3 | 1.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.3 | 4.6 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.3 | 3.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 | 0.8 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.3 | 5.9 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.3 | 0.3 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.3 | 0.8 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.3 | 3.9 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.3 | 2.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.3 | 0.5 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.3 | 1.0 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.3 | 4.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.3 | 0.8 | GO:0060629 | meiotic DNA double-strand break formation(GO:0042138) regulation of homologous chromosome segregation(GO:0060629) |
| 0.3 | 0.3 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.3 | 0.8 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.3 | 0.3 | GO:0044843 | cell cycle G1/S phase transition(GO:0044843) |
| 0.3 | 1.8 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.2 | 3.5 | GO:0019079 | viral genome replication(GO:0019079) |
| 0.2 | 5.7 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.2 | 3.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 | 1.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
| 0.2 | 4.2 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.2 | 6.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.2 | 0.5 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.2 | 3.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.2 | 1.7 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.2 | 15.9 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.2 | 4.8 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.2 | 2.4 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.2 | 6.0 | GO:0007616 | long-term memory(GO:0007616) |
| 0.2 | 1.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.2 | 2.9 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.2 | 1.2 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.2 | 2.6 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
| 0.2 | 0.2 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.2 | 1.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.2 | 3.8 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.2 | 1.7 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.2 | 3.1 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.2 | 5.9 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.2 | 1.4 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.2 | 0.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.2 | 0.7 | GO:0030100 | regulation of endocytosis(GO:0030100) |
| 0.2 | 0.5 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.2 | 2.6 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.2 | 1.2 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.2 | 0.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.2 | 3.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.2 | 0.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.2 | 1.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.2 | 17.0 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
| 0.2 | 0.5 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.2 | 1.1 | GO:0009597 | detection of virus(GO:0009597) |
| 0.2 | 3.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.2 | 2.7 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
| 0.2 | 0.7 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 | 1.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.2 | 0.7 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.2 | 0.7 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.2 | 1.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.2 | 3.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.2 | 0.7 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.2 | 0.9 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.2 | 1.1 | GO:0007512 | adult heart development(GO:0007512) |
| 0.2 | 1.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.2 | 0.4 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.2 | 1.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.2 | 0.7 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.2 | 0.4 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.2 | 6.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.2 | 0.7 | GO:0007343 | egg activation(GO:0007343) female pronucleus assembly(GO:0035038) |
| 0.2 | 2.0 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 | 0.7 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
| 0.2 | 0.2 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 0.2 | 0.6 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.2 | 1.9 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 0.2 | 0.9 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.2 | 1.3 | GO:2000404 | regulation of T cell migration(GO:2000404) |
| 0.2 | 1.5 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
| 0.2 | 0.4 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.2 | 3.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.2 | 1.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 | 0.2 | GO:0072537 | fibroblast activation(GO:0072537) |
| 0.2 | 0.8 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.2 | 1.1 | GO:0006404 | RNA import into nucleus(GO:0006404) |
| 0.2 | 5.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.2 | 0.2 | GO:0090403 | negative regulation of icosanoid secretion(GO:0032304) oxidative stress-induced premature senescence(GO:0090403) |
| 0.2 | 0.8 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.2 | 1.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.2 | 1.7 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) nuclear migration along microfilament(GO:0031022) |
| 0.2 | 0.6 | GO:0051685 | maintenance of ER location(GO:0051685) |
| 0.2 | 3.3 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.2 | 0.8 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.2 | 1.0 | GO:0071872 | cellular response to epinephrine stimulus(GO:0071872) |
| 0.2 | 0.8 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.2 | 0.2 | GO:0046959 | habituation(GO:0046959) |
| 0.2 | 2.5 | GO:0097205 | renal filtration(GO:0097205) |
| 0.2 | 1.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.2 | 1.0 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.2 | 2.7 | GO:0001738 | establishment of planar polarity(GO:0001736) morphogenesis of a polarized epithelium(GO:0001738) establishment of tissue polarity(GO:0007164) |
| 0.2 | 1.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.2 | 11.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.2 | 0.2 | GO:0035878 | nail development(GO:0035878) |
| 0.2 | 0.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.2 | 1.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 | 11.8 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.2 | 1.4 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.2 | 2.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.2 | 2.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.2 | 2.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 | 1.0 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.2 | 1.2 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.2 | 1.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.2 | 0.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.2 | 1.6 | GO:0032439 | endosome localization(GO:0032439) |
| 0.2 | 0.4 | GO:0060936 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) |
| 0.2 | 1.4 | GO:0042471 | ear morphogenesis(GO:0042471) |
| 0.2 | 1.2 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
| 0.2 | 1.2 | GO:0070778 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
| 0.2 | 0.4 | GO:0009299 | mRNA transcription(GO:0009299) |
| 0.2 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.2 | 8.8 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.2 | 2.4 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.2 | 1.0 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.2 | 0.8 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.2 | 3.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.2 | 0.8 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
| 0.2 | 1.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 0.2 | 0.4 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.2 | 5.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.2 | 0.8 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.2 | 1.5 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) response to glycoprotein(GO:1904587) |
| 0.2 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.2 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.2 | 0.9 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.2 | 5.5 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
| 0.2 | 0.9 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.2 | 3.8 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
| 0.2 | 2.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.2 | 16.6 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.2 | 16.2 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.2 | 0.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
| 0.2 | 0.6 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.2 | 7.0 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
| 0.2 | 1.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.2 | 2.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.2 | 2.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 | 2.4 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.2 | 2.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.2 | 0.4 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.2 | 6.2 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.2 | 1.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.2 | 1.6 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.2 | 0.7 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.2 | 1.1 | GO:0030326 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
| 0.2 | 0.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 | 2.2 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
| 0.2 | 0.2 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
| 0.2 | 2.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.2 | 1.1 | GO:0042026 | protein refolding(GO:0042026) |
| 0.2 | 1.2 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.2 | 3.7 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.2 | 0.7 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.2 | 0.5 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.2 | 1.9 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 0.2 | 1.2 | GO:0007623 | circadian rhythm(GO:0007623) |
| 0.2 | 1.0 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
| 0.2 | 2.6 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.2 | 1.7 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.2 | 0.7 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.2 | 3.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.2 | 1.2 | GO:0033044 | regulation of chromosome organization(GO:0033044) |
| 0.2 | 0.7 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
| 0.2 | 7.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.2 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.2 | 0.2 | GO:0090298 | base-excision repair, DNA ligation(GO:0006288) regulation of mitochondrial DNA replication(GO:0090296) negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.2 | 1.0 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.2 | 3.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.2 | 0.8 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.2 | 0.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.2 | 0.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.2 | 3.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.2 | 0.7 | GO:0021984 | adenohypophysis development(GO:0021984) |
| 0.2 | 1.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.2 | 1.0 | GO:0051918 | regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
| 0.2 | 1.2 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.2 | 7.2 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.2 | 0.3 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
| 0.2 | 2.0 | GO:0031638 | zymogen activation(GO:0031638) |
| 0.2 | 1.5 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.2 | 0.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.2 | 0.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 | 0.8 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.2 | 2.1 | GO:0061072 | iris morphogenesis(GO:0061072) |
| 0.2 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.2 | 0.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.2 | 2.4 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
| 0.2 | 2.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.2 | 6.8 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.2 | 0.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.2 | 0.6 | GO:0044417 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.2 | 0.5 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
| 0.2 | 0.6 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.2 | 0.8 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.2 | 1.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.2 | 0.8 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.2 | 2.3 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.2 | 2.0 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.2 | 0.9 | GO:0032570 | response to progesterone(GO:0032570) |
| 0.2 | 0.3 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
| 0.2 | 0.2 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.2 | 0.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.2 | 1.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.2 | 2.1 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
| 0.2 | 0.2 | GO:0090224 | regulation of spindle organization(GO:0090224) |
| 0.1 | 1.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 0.3 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 | 0.7 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.1 | 0.7 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
| 0.1 | 19.0 | GO:0002576 | platelet degranulation(GO:0002576) |
| 0.1 | 0.4 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.1 | 3.3 | GO:2001273 | regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.1 | 0.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 | 0.7 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.1 | 0.4 | GO:1903059 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) regulation of protein lipidation(GO:1903059) negative regulation of protein lipidation(GO:1903060) |
| 0.1 | 1.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 0.6 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 0.6 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 0.6 | GO:0071625 | vocalization behavior(GO:0071625) |
| 0.1 | 1.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.1 | 0.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) |
| 0.1 | 1.0 | GO:0044117 | growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) |
| 0.1 | 1.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 | 3.7 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
| 0.1 | 1.0 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.1 | 0.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.1 | 1.8 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 | 0.4 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.1 | 2.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.1 | 1.1 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.1 | 1.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.1 | 0.7 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.1 | 0.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
| 0.1 | 1.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 | 0.5 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.1 | 2.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 | 3.0 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
| 0.1 | 1.8 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.1 | 1.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 | 1.8 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.1 | 0.5 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.1 | 0.4 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.1 | 0.7 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.1 | 0.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 | 0.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.1 | 7.0 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 | 0.4 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.1 | 0.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 2.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.1 | 0.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.1 | 3.2 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
| 0.1 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 0.5 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 | 2.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 | 0.3 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.1 | 0.9 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
| 0.1 | 0.4 | GO:0071106 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.1 | 0.6 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 | 1.0 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.1 | 1.3 | GO:0042384 | cilium assembly(GO:0042384) |
| 0.1 | 1.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 1.2 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
| 0.1 | 0.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
| 0.1 | 0.5 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.1 | 0.5 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.1 | 4.9 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.1 | 1.9 | GO:0097581 | lamellipodium organization(GO:0097581) |
| 0.1 | 0.8 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.1 | 2.1 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.1 | 0.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 | 0.2 | GO:0050820 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
| 0.1 | 4.1 | GO:0006101 | citrate metabolic process(GO:0006101) |
| 0.1 | 0.4 | GO:0061055 | myotome development(GO:0061055) |
| 0.1 | 0.7 | GO:0072092 | ureteric bud invasion(GO:0072092) |
| 0.1 | 0.2 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.1 | 0.5 | GO:0000050 | urea cycle(GO:0000050) |
| 0.1 | 0.6 | GO:0090656 | t-circle formation(GO:0090656) |
| 0.1 | 0.2 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
| 0.1 | 0.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 1.1 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
| 0.1 | 0.3 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 | 2.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 | 1.9 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
| 0.1 | 1.2 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 | 0.5 | GO:1990736 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 0.1 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 | 0.2 | GO:0044026 | DNA hypermethylation(GO:0044026) |
| 0.1 | 0.2 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.1 | 0.9 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.1 | 1.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 | 2.2 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 | 2.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 0.1 | 0.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 | 0.9 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.1 | 0.8 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.1 | 0.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
| 0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 0.8 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.1 | 1.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.1 | 0.7 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 | 1.2 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.1 | 0.5 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.1 | 0.5 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
| 0.1 | 0.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 | 5.9 | GO:0003341 | cilium movement(GO:0003341) |
| 0.1 | 0.4 | GO:0009651 | response to salt stress(GO:0009651) |
| 0.1 | 0.1 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
| 0.1 | 0.1 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.1 | 0.5 | GO:0035904 | aorta development(GO:0035904) |
| 0.1 | 0.3 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.1 | 1.9 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
| 0.1 | 0.3 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
| 0.1 | 2.7 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
| 0.1 | 1.3 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 | 1.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.1 | 5.2 | GO:0043297 | apical junction assembly(GO:0043297) |
| 0.1 | 1.2 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 | 0.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 | 1.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.1 | 1.8 | GO:0030518 | intracellular steroid hormone receptor signaling pathway(GO:0030518) |
| 0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.1 | 0.3 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.1 | 1.6 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.1 | 0.3 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 0.1 | 0.4 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.1 | 1.2 | GO:0036065 | fucosylation(GO:0036065) |
| 0.1 | 0.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 0.1 | 0.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 | 1.1 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.1 | 5.1 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.1 | 0.3 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.1 | 1.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.1 | 9.5 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
| 0.1 | 0.9 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
| 0.1 | 3.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.1 | 0.3 | GO:0072141 | renal interstitial fibroblast development(GO:0072141) |
| 0.1 | 6.5 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.1 | 4.3 | GO:1905037 | autophagosome organization(GO:1905037) |
| 0.1 | 0.5 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.1 | 0.4 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 | 0.8 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.1 | 0.4 | GO:0044839 | cell cycle G2/M phase transition(GO:0044839) |
| 0.1 | 0.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.1 | 0.4 | GO:0035822 | gene conversion(GO:0035822) |
| 0.1 | 1.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.1 | 0.7 | GO:0002739 | regulation of cytokine secretion involved in immune response(GO:0002739) |
| 0.1 | 0.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.1 | 0.5 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 | 0.3 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 | 0.5 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 | 4.7 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 3.4 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.1 | 0.4 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.1 | 1.0 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
| 0.1 | 0.5 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
| 0.1 | 0.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.1 | 1.7 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 0.2 | GO:0031047 | gene silencing by RNA(GO:0031047) |
| 0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 | 1.4 | GO:0006513 | protein monoubiquitination(GO:0006513) |
| 0.1 | 0.7 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 | 0.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 | 0.3 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 | 1.0 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.1 | 1.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.1 | 2.5 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.1 | 0.2 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.1 | 0.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.1 | 0.2 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.1 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.1 | 0.5 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.1 | 2.7 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.1 | 0.9 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.1 | 0.2 | GO:0042701 | progesterone secretion(GO:0042701) regulation of progesterone secretion(GO:2000870) |
| 0.1 | 0.9 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) |
| 0.1 | 0.5 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.1 | 0.2 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
| 0.1 | 3.8 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
| 0.1 | 3.7 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
| 0.1 | 0.1 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
| 0.1 | 1.7 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 | 0.2 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.1 | 0.4 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.1 | 0.2 | GO:0071317 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.1 | 0.4 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.1 | 0.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 2.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 0.4 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
| 0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 0.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.1 | 0.5 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
| 0.1 | 0.2 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.1 | 0.8 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.1 | 0.1 | GO:0048265 | response to pain(GO:0048265) |
| 0.1 | 0.2 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.1 | 0.7 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
| 0.1 | 0.1 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.1 | 0.3 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.1 | 0.8 | GO:0044070 | regulation of anion transport(GO:0044070) |
| 0.1 | 0.6 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
| 0.1 | 0.3 | GO:0051261 | protein depolymerization(GO:0051261) |
| 0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
| 0.1 | 0.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 | 0.6 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.1 | 1.5 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.1 | 0.3 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.1 | 2.2 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
| 0.1 | 0.7 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 | 0.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 | 4.5 | GO:0016575 | histone deacetylation(GO:0016575) |
| 0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.1 | 0.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.1 | 1.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.1 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
| 0.1 | 0.1 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.1 | 0.5 | GO:0042428 | serotonin metabolic process(GO:0042428) |
| 0.1 | 0.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.1 | 0.5 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.1 | 0.2 | GO:0031644 | regulation of neurological system process(GO:0031644) |
| 0.1 | 0.2 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
| 0.1 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 0.9 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 | 1.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.1 | 0.2 | GO:0044782 | cilium organization(GO:0044782) |
| 0.1 | 1.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 | 0.8 | GO:0001895 | retina homeostasis(GO:0001895) |
| 0.1 | 0.3 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 | 0.2 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.1 | 0.1 | GO:0050893 | sensory processing(GO:0050893) |
| 0.1 | 0.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 | 1.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.1 | 0.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 | 0.1 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
| 0.1 | 0.8 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.1 | 0.9 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 0.1 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
| 0.1 | 0.4 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
| 0.1 | 0.1 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.1 | 0.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
| 0.1 | 0.3 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.1 | 0.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 0.7 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 | 0.3 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.0 | 0.4 | GO:0042148 | strand invasion(GO:0042148) |
| 0.0 | 0.3 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.0 | 0.2 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.0 | 0.2 | GO:2000145 | regulation of cell motility(GO:2000145) |
| 0.0 | 7.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 1.7 | GO:0002456 | T cell mediated immunity(GO:0002456) |
| 0.0 | 0.5 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 | 0.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
| 0.0 | 0.0 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.0 | 1.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 0.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.0 | 0.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 | 0.2 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.0 | 0.3 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.0 | 0.2 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.0 | 0.5 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.0 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.0 | 1.1 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
| 0.0 | 0.4 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
| 0.0 | 0.3 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.0 | 0.1 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
| 0.0 | 0.3 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.0 | 0.5 | GO:1902593 | single-organism nuclear import(GO:1902593) |
| 0.0 | 0.6 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
| 0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.0 | 0.0 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.0 | 0.1 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.0 | 1.0 | GO:0034333 | adherens junction assembly(GO:0034333) |
| 0.0 | 0.3 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.0 | 0.1 | GO:0097359 | UDP-glucosylation(GO:0097359) |
| 0.0 | 0.1 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 0.0 | 0.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 | 0.1 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.0 | 0.2 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.0 | 0.4 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.0 | 0.2 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
| 0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.0 | 0.9 | GO:0030317 | sperm motility(GO:0030317) |
| 0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.0 | 0.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
| 0.0 | 0.2 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.0 | 0.0 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 | 0.8 | GO:0016197 | endosomal transport(GO:0016197) |
| 0.0 | 0.1 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.0 | 0.1 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.0 | 0.0 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.0 | 0.0 | GO:0009451 | RNA modification(GO:0009451) |
| 0.0 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.0 | 0.8 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.0 | 0.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
| 0.0 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.0 | 0.1 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.0 | 0.1 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 | 0.2 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.0 | 0.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 | 0.6 | GO:0043242 | negative regulation of protein complex disassembly(GO:0043242) |
| 0.0 | 0.5 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 | 0.0 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 | 0.1 | GO:2000391 | positive regulation of neutrophil extravasation(GO:2000391) |
| 0.0 | 0.0 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.0 | 0.0 | GO:0000278 | mitotic cell cycle(GO:0000278) |
| 0.0 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 | 0.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.0 | 0.1 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
| 0.0 | 0.1 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.0 | 0.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 | 0.0 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.0 | 0.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.0 | 0.4 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 | 0.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 | 0.0 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
| 0.0 | 0.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 0.1 | GO:0006833 | water transport(GO:0006833) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.2 | 32.8 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 3.8 | 7.5 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 3.2 | 13.0 | GO:0031213 | RSF complex(GO:0031213) |
| 3.1 | 18.8 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 2.9 | 8.7 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
| 2.8 | 19.7 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 2.8 | 22.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 2.7 | 16.1 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 2.4 | 7.3 | GO:1990032 | parallel fiber(GO:1990032) |
| 2.4 | 12.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 2.4 | 18.8 | GO:0070876 | SOSS complex(GO:0070876) |
| 2.3 | 7.0 | GO:0075341 | host cell PML body(GO:0075341) |
| 2.3 | 11.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 2.2 | 11.0 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 2.0 | 16.3 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
| 2.0 | 6.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 2.0 | 15.7 | GO:0097452 | GAIT complex(GO:0097452) |
| 2.0 | 33.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 1.9 | 9.7 | GO:0071942 | XPC complex(GO:0071942) |
| 1.9 | 19.3 | GO:0005955 | calcineurin complex(GO:0005955) |
| 1.9 | 5.8 | GO:0005745 | m-AAA complex(GO:0005745) |
| 1.9 | 3.7 | GO:0035061 | interchromatin granule(GO:0035061) |
| 1.8 | 5.5 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 1.8 | 48.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 1.8 | 12.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 1.6 | 8.2 | GO:0044393 | microspike(GO:0044393) |
| 1.6 | 9.6 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 1.5 | 6.1 | GO:0016939 | kinesin II complex(GO:0016939) |
| 1.5 | 1.5 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 1.5 | 6.0 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 1.5 | 4.4 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 1.5 | 24.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 1.5 | 11.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 1.4 | 2.9 | GO:0001740 | Barr body(GO:0001740) |
| 1.4 | 7.1 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 1.4 | 7.0 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 1.4 | 39.3 | GO:0071564 | npBAF complex(GO:0071564) |
| 1.4 | 1.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 1.4 | 6.9 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 1.4 | 8.2 | GO:0097513 | myosin II filament(GO:0097513) |
| 1.3 | 1.3 | GO:1990246 | uniplex complex(GO:1990246) |
| 1.3 | 15.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 1.3 | 15.6 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 1.3 | 12.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 1.3 | 1.3 | GO:0097427 | microtubule bundle(GO:0097427) |
| 1.3 | 3.8 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 1.2 | 3.7 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 1.2 | 4.9 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
| 1.2 | 2.5 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 1.2 | 29.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 1.2 | 24.0 | GO:0097227 | sperm annulus(GO:0097227) |
| 1.2 | 2.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 1.2 | 3.6 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 1.2 | 17.8 | GO:0097470 | ribbon synapse(GO:0097470) |
| 1.2 | 18.9 | GO:0043219 | lateral loop(GO:0043219) |
| 1.2 | 10.6 | GO:0051286 | cell tip(GO:0051286) |
| 1.1 | 8.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 1.1 | 6.9 | GO:0044308 | axonal spine(GO:0044308) |
| 1.1 | 1.1 | GO:1903349 | omegasome membrane(GO:1903349) |
| 1.1 | 2.2 | GO:0070187 | telosome(GO:0070187) |
| 1.1 | 15.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 1.1 | 7.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 1.1 | 25.9 | GO:0097386 | glial cell projection(GO:0097386) |
| 1.1 | 16.1 | GO:0032039 | integrator complex(GO:0032039) |
| 1.0 | 11.5 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 1.0 | 4.1 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 1.0 | 38.0 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 1.0 | 7.2 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 1.0 | 42.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 1.0 | 16.0 | GO:0032426 | stereocilium tip(GO:0032426) |
| 1.0 | 41.8 | GO:0030057 | desmosome(GO:0030057) |
| 1.0 | 13.8 | GO:0001939 | female pronucleus(GO:0001939) |
| 1.0 | 11.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 1.0 | 7.8 | GO:0071203 | WASH complex(GO:0071203) |
| 1.0 | 4.8 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 1.0 | 6.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 1.0 | 11.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.9 | 1.9 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.9 | 8.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.9 | 16.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.9 | 7.4 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.9 | 2.7 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 0.9 | 20.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.9 | 4.4 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.9 | 9.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.9 | 1.8 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.9 | 4.4 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
| 0.9 | 3.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.9 | 3.5 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.9 | 4.3 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.9 | 8.6 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.8 | 6.5 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.8 | 2.4 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.8 | 7.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.8 | 3.2 | GO:0060187 | cell pole(GO:0060187) |
| 0.8 | 4.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.8 | 1.6 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.8 | 4.7 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 0.8 | 11.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.8 | 6.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.8 | 47.1 | GO:0043034 | costamere(GO:0043034) |
| 0.8 | 3.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.8 | 14.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.8 | 10.1 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.8 | 2.3 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.8 | 0.8 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.8 | 53.6 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.8 | 3.0 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.7 | 6.0 | GO:0016589 | NURF complex(GO:0016589) |
| 0.7 | 2.2 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.7 | 5.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.7 | 8.0 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.7 | 5.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.7 | 3.6 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.7 | 0.7 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.7 | 3.5 | GO:0032449 | CBM complex(GO:0032449) |
| 0.7 | 6.1 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.7 | 19.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.7 | 13.6 | GO:0090543 | Flemming body(GO:0090543) |
| 0.7 | 9.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.7 | 49.0 | GO:0002102 | podosome(GO:0002102) |
| 0.7 | 84.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.7 | 3.9 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.7 | 4.6 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.7 | 1.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.6 | 2.6 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.6 | 13.6 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.6 | 12.2 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.6 | 0.6 | GO:0030689 | Noc complex(GO:0030689) |
| 0.6 | 8.9 | GO:0016342 | catenin complex(GO:0016342) |
| 0.6 | 5.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.6 | 8.8 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.6 | 1.9 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.6 | 21.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.6 | 3.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.6 | 9.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.6 | 1.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.6 | 9.0 | GO:0010369 | chromocenter(GO:0010369) |
| 0.6 | 8.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.6 | 19.2 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.6 | 16.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.6 | 1.8 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.6 | 7.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.6 | 2.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.6 | 4.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.6 | 4.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.6 | 0.6 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.6 | 32.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.6 | 6.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.6 | 3.9 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.6 | 1.1 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 0.5 | 3.2 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.5 | 1.6 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.5 | 0.5 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.5 | 7.9 | GO:0045179 | apical cortex(GO:0045179) |
| 0.5 | 1.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.5 | 2.6 | GO:0031417 | NatC complex(GO:0031417) |
| 0.5 | 9.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.5 | 5.2 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
| 0.5 | 14.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.5 | 1.0 | GO:0055087 | Ski complex(GO:0055087) |
| 0.5 | 4.6 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.5 | 1.5 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.5 | 86.0 | GO:0016605 | PML body(GO:0016605) |
| 0.5 | 1.5 | GO:0008623 | CHRAC(GO:0008623) |
| 0.5 | 2.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
| 0.5 | 8.5 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.5 | 3.0 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.5 | 0.5 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.5 | 66.8 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.5 | 12.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.5 | 6.9 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.5 | 1.5 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.5 | 0.5 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 0.5 | 0.5 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.5 | 2.9 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.5 | 8.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.5 | 4.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.5 | 34.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.5 | 38.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.5 | 4.2 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.5 | 9.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.5 | 12.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.5 | 22.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.5 | 2.7 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.5 | 16.7 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.5 | 2.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.4 | 6.3 | GO:0008091 | spectrin(GO:0008091) |
| 0.4 | 8.4 | GO:0045180 | basal cortex(GO:0045180) |
| 0.4 | 5.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.4 | 2.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.4 | 6.1 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.4 | 1.7 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.4 | 1.7 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.4 | 1.3 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 0.4 | 3.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.4 | 6.0 | GO:0031045 | dense core granule(GO:0031045) |
| 0.4 | 14.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.4 | 52.2 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.4 | 2.5 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.4 | 1.7 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.4 | 8.8 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.4 | 0.8 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 0.4 | 40.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.4 | 4.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.4 | 30.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.4 | 0.8 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.4 | 6.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.4 | 10.3 | GO:0071437 | invadopodium(GO:0071437) |
| 0.4 | 9.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.4 | 1.2 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 0.4 | 4.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.4 | 42.9 | GO:0005811 | lipid particle(GO:0005811) |
| 0.4 | 1.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.4 | 1.6 | GO:1990745 | EARP complex(GO:1990745) |
| 0.4 | 16.4 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.4 | 0.8 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.4 | 3.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.4 | 3.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.4 | 2.7 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.4 | 4.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.4 | 14.5 | GO:0005921 | gap junction(GO:0005921) |
| 0.4 | 1.9 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.4 | 16.5 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.4 | 1.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.4 | 6.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.4 | 8.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.4 | 6.1 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.4 | 2.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.4 | 1.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.4 | 22.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.4 | 1.4 | GO:0072534 | perineuronal net(GO:0072534) |
| 0.3 | 7.3 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.3 | 8.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.3 | 1.7 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.3 | 1.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.3 | 4.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.3 | 2.7 | GO:0031415 | NatA complex(GO:0031415) |
| 0.3 | 2.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.3 | 1.3 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.3 | 1.6 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.3 | 1.9 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.3 | 0.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.3 | 5.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.3 | 5.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.3 | 4.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.3 | 0.6 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
| 0.3 | 1.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
| 0.3 | 1.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.3 | 6.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.3 | 77.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.3 | 3.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.3 | 0.9 | GO:0005595 | collagen type XII trimer(GO:0005595) |
| 0.3 | 2.0 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
| 0.3 | 1.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.3 | 1.1 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.3 | 8.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.3 | 1.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.3 | 7.7 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.3 | 0.3 | GO:0042641 | actomyosin(GO:0042641) |
| 0.3 | 4.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.3 | 2.5 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.3 | 4.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.3 | 2.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.3 | 1.4 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.3 | 0.8 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.3 | 16.5 | GO:0000786 | nucleosome(GO:0000786) |
| 0.3 | 1.9 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.3 | 3.5 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.3 | 3.2 | GO:0072487 | MSL complex(GO:0072487) |
| 0.3 | 4.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.3 | 6.6 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.3 | 30.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.3 | 2.1 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.3 | 5.5 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.3 | 3.6 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.3 | 2.0 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.3 | 1.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.2 | 1.0 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.2 | 4.4 | GO:0000145 | exocyst(GO:0000145) |
| 0.2 | 0.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.2 | 11.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.2 | 1.2 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.2 | 5.5 | GO:0030424 | axon(GO:0030424) |
| 0.2 | 1.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.2 | 1.4 | GO:0036019 | endolysosome(GO:0036019) endolysosome membrane(GO:0036020) |
| 0.2 | 4.1 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
| 0.2 | 12.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.2 | 5.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.2 | 0.7 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.2 | 0.7 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.2 | 9.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.2 | 51.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.2 | 2.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.2 | 1.4 | GO:0034448 | EGO complex(GO:0034448) |
| 0.2 | 37.4 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.2 | 29.8 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.2 | 1.3 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.2 | 3.6 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.2 | 4.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.2 | 1.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.2 | 9.1 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.2 | 0.7 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.2 | 0.7 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.2 | 21.7 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.2 | 0.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.2 | 0.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.2 | 0.6 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.2 | 4.3 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.2 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.2 | 1.1 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.2 | 3.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.2 | 1.9 | GO:0070461 | SAGA-type complex(GO:0070461) |
| 0.2 | 0.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.2 | 2.2 | GO:0012505 | endomembrane system(GO:0012505) |
| 0.2 | 0.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.2 | 0.4 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.2 | 0.4 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.2 | 84.4 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.2 | 1.5 | GO:0030478 | actin cap(GO:0030478) |
| 0.2 | 9.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.2 | 14.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.2 | 0.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.2 | 0.6 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
| 0.2 | 6.9 | GO:0030286 | dynein complex(GO:0030286) |
| 0.2 | 12.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.2 | 3.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.2 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.2 | 0.7 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 0.2 | 1.0 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.2 | 0.9 | GO:0005606 | laminin-1 complex(GO:0005606) |
| 0.2 | 1.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.2 | 2.0 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.2 | 1.7 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.2 | 0.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.2 | 1.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 0.2 | 7.8 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.2 | 24.2 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.2 | 19.1 | GO:0034399 | nuclear periphery(GO:0034399) |
| 0.2 | 1.4 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.2 | 1.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.2 | 1.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.2 | 1.9 | GO:0030904 | retromer complex(GO:0030904) |
| 0.2 | 6.0 | GO:0043204 | perikaryon(GO:0043204) |
| 0.2 | 4.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.1 | 2.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.1 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.1 | 2.9 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.1 | 6.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 0.7 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 0.1 | 5.1 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.1 | 0.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.1 | 2.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.1 | 6.1 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 2.6 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.1 | 4.1 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 0.9 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.1 | 1.0 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.1 | 0.8 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.1 | 5.7 | GO:0005604 | basement membrane(GO:0005604) |
| 0.1 | 1.5 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.1 | 0.8 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.1 | 2.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.1 | 0.8 | GO:0031430 | M band(GO:0031430) |
| 0.1 | 0.4 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.1 | 0.4 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.1 | 39.0 | GO:0016604 | nuclear body(GO:0016604) |
| 0.1 | 1.7 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 2.7 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 1.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.5 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.1 | 0.5 | GO:0031251 | PAN complex(GO:0031251) |
| 0.1 | 2.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.1 | 5.4 | GO:0000922 | spindle pole(GO:0000922) |
| 0.1 | 3.6 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.1 | 1.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 0.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 15.5 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.1 | 2.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.1 | 0.6 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 9.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 0.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.1 | 0.6 | GO:0043218 | compact myelin(GO:0043218) |
| 0.1 | 4.7 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.1 | 0.7 | GO:0097413 | Lewy body(GO:0097413) |
| 0.1 | 1.4 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.1 | 1.4 | GO:0042599 | lamellar body(GO:0042599) |
| 0.1 | 1.5 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.1 | 0.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.1 | 1.3 | GO:0030175 | filopodium(GO:0030175) |
| 0.1 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.1 | 0.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.1 | 0.4 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.1 | 13.0 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 0.8 | GO:0030118 | clathrin coat(GO:0030118) |
| 0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
| 0.1 | 2.3 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 0.2 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 2.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.1 | 0.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.1 | 1.9 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 0.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.1 | 2.3 | GO:0044453 | nuclear membrane part(GO:0044453) |
| 0.1 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.1 | 10.5 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
| 0.1 | 2.7 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 1.5 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.1 | 0.5 | GO:0043203 | axon hillock(GO:0043203) |
| 0.1 | 6.0 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.1 | 0.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 1.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.1 | 0.2 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.1 | 8.2 | GO:0005769 | early endosome(GO:0005769) |
| 0.1 | 0.2 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.1 | 5.5 | GO:0098858 | actin-based cell projection(GO:0098858) |
| 0.1 | 0.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
| 0.1 | 0.4 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.1 | 9.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.1 | 0.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.1 | 1.2 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 17.3 | GO:0005911 | cell-cell junction(GO:0005911) |
| 0.1 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.1 | 7.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 0.2 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
| 0.1 | 6.2 | GO:0005741 | mitochondrial outer membrane(GO:0005741) organelle outer membrane(GO:0031968) |
| 0.1 | 0.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.1 | 7.8 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.1 | 0.4 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
| 0.1 | 6.0 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.1 | 0.4 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 0.4 | GO:0031514 | motile cilium(GO:0031514) |
| 0.1 | 1.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 1.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 5.1 | GO:0055029 | nuclear DNA-directed RNA polymerase complex(GO:0055029) |
| 0.0 | 0.2 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.0 | 1.7 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.0 | 0.3 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.0 | 0.6 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.0 | 0.3 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.0 | 4.5 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.0 | 5.1 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 2.2 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.0 | 1.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 0.1 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.0 | 0.0 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.0 | 0.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 2.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 3.0 | GO:0030018 | Z disc(GO:0030018) |
| 0.0 | 0.6 | GO:0046930 | pore complex(GO:0046930) |
| 0.0 | 0.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.0 | 0.1 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
| 0.0 | 1.0 | GO:0036126 | sperm flagellum(GO:0036126) |
| 0.0 | 0.8 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.0 | 0.1 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.0 | 3.3 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.0 | 33.9 | GO:0005794 | Golgi apparatus(GO:0005794) |
| 0.0 | 0.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.0 | 0.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 1.1 | GO:0031252 | cell leading edge(GO:0031252) |
| 0.0 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 1.0 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 0.1 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 0.0 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.0 | 0.5 | GO:1990777 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
| 0.0 | 0.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 0.3 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.0 | 0.7 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.4 | 19.1 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 4.9 | 34.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 3.9 | 15.8 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 3.9 | 11.6 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 3.0 | 42.6 | GO:0038132 | neuregulin binding(GO:0038132) |
| 2.9 | 34.4 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 2.8 | 11.4 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 2.8 | 8.3 | GO:0086039 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
| 2.6 | 10.5 | GO:0008431 | vitamin E binding(GO:0008431) |
| 2.6 | 7.8 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 2.5 | 7.4 | GO:1902271 | D3 vitamins binding(GO:1902271) |
| 2.4 | 7.3 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 2.4 | 11.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 2.4 | 9.4 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 2.3 | 41.6 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 2.3 | 9.0 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 2.2 | 6.7 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 2.2 | 6.7 | GO:0016768 | spermine synthase activity(GO:0016768) |
| 2.2 | 17.7 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 2.1 | 51.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 2.0 | 6.0 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
| 2.0 | 6.0 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 2.0 | 16.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 2.0 | 9.9 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 2.0 | 17.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 2.0 | 43.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 1.9 | 3.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 1.9 | 7.7 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 1.9 | 5.7 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 1.9 | 13.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 1.8 | 10.9 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 1.8 | 9.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 1.8 | 5.4 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 1.8 | 8.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 1.7 | 10.5 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 1.7 | 27.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 1.7 | 5.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 1.7 | 6.6 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 1.7 | 5.0 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 1.6 | 4.9 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
| 1.6 | 21.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 1.6 | 4.9 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 1.6 | 3.2 | GO:0035939 | microsatellite binding(GO:0035939) |
| 1.6 | 4.7 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 1.6 | 17.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 1.6 | 4.7 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 1.5 | 7.7 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 1.5 | 6.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 1.5 | 6.1 | GO:0070052 | collagen V binding(GO:0070052) |
| 1.5 | 6.0 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 1.5 | 5.9 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 1.5 | 10.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 1.5 | 8.9 | GO:0039552 | RIG-I binding(GO:0039552) |
| 1.4 | 11.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 1.4 | 10.0 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 1.4 | 8.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 1.4 | 4.2 | GO:0032093 | SAM domain binding(GO:0032093) |
| 1.4 | 67.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 1.4 | 6.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 1.4 | 13.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 1.3 | 8.1 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 1.3 | 19.7 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 1.3 | 11.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 1.3 | 7.9 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 1.3 | 2.6 | GO:0035242 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 1.3 | 32.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 1.3 | 3.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 1.3 | 1.3 | GO:0005522 | profilin binding(GO:0005522) |
| 1.3 | 11.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 1.3 | 11.4 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 1.3 | 5.0 | GO:0036033 | mediator complex binding(GO:0036033) |
| 1.3 | 3.8 | GO:0030984 | kininogen binding(GO:0030984) |
| 1.2 | 6.2 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 1.2 | 3.7 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 1.2 | 1.2 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 1.2 | 3.7 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 1.2 | 12.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 1.2 | 3.7 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 1.2 | 4.8 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 1.2 | 8.3 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 1.2 | 14.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 1.2 | 17.7 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 1.2 | 4.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 1.2 | 5.9 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 1.2 | 3.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 1.2 | 3.5 | GO:0008398 | sterol 14-demethylase activity(GO:0008398) |
| 1.2 | 3.5 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 1.2 | 6.9 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 1.1 | 8.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 1.1 | 3.4 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 1.1 | 20.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 1.1 | 4.5 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 1.1 | 3.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 1.1 | 3.3 | GO:0030276 | clathrin binding(GO:0030276) |
| 1.1 | 3.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
| 1.1 | 5.5 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 1.1 | 2.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 1.1 | 8.7 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 1.1 | 11.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 1.1 | 2.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 1.1 | 4.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 1.1 | 13.8 | GO:0031386 | protein tag(GO:0031386) |
| 1.1 | 3.2 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 1.1 | 10.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 1.1 | 3.2 | GO:0046970 | NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
| 1.0 | 9.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 1.0 | 4.1 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 1.0 | 3.1 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 1.0 | 4.1 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 1.0 | 4.1 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 1.0 | 1.0 | GO:0090541 | MIT domain binding(GO:0090541) |
| 1.0 | 11.2 | GO:0030911 | TPR domain binding(GO:0030911) |
| 1.0 | 9.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 1.0 | 8.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 1.0 | 5.0 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 1.0 | 26.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 1.0 | 7.0 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 1.0 | 22.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 1.0 | 1.0 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
| 1.0 | 3.0 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 1.0 | 3.0 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 1.0 | 2.9 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 1.0 | 7.7 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
| 1.0 | 2.9 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 1.0 | 3.8 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 1.0 | 12.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.9 | 4.7 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.9 | 3.8 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.9 | 33.7 | GO:0043236 | laminin binding(GO:0043236) |
| 0.9 | 2.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.9 | 37.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.9 | 4.6 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.9 | 1.9 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.9 | 4.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.9 | 2.8 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.9 | 3.7 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.9 | 7.4 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.9 | 7.3 | GO:0071253 | connexin binding(GO:0071253) |
| 0.9 | 4.6 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.9 | 10.0 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.9 | 4.5 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.9 | 3.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.9 | 4.5 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.9 | 6.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.9 | 5.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.9 | 30.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.9 | 5.3 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.9 | 4.4 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.9 | 7.9 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.9 | 3.5 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 0.9 | 10.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.9 | 10.4 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.9 | 4.3 | GO:0089720 | caspase binding(GO:0089720) |
| 0.9 | 3.4 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
| 0.9 | 4.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.8 | 4.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.8 | 2.5 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.8 | 3.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.8 | 5.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.8 | 2.5 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.8 | 4.2 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.8 | 2.5 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.8 | 5.9 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.8 | 2.5 | GO:0030626 | U12 snRNA binding(GO:0030626) |
| 0.8 | 2.5 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
| 0.8 | 5.0 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.8 | 4.1 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.8 | 15.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.8 | 20.5 | GO:0016918 | retinal binding(GO:0016918) |
| 0.8 | 3.3 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.8 | 4.9 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.8 | 4.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.8 | 2.4 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.8 | 29.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.8 | 14.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.8 | 2.4 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.8 | 6.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.8 | 3.2 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.8 | 39.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.8 | 7.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.8 | 5.5 | GO:0070728 | leucine binding(GO:0070728) |
| 0.8 | 3.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.8 | 11.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.8 | 4.6 | GO:0052844 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.8 | 8.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.8 | 3.8 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.8 | 43.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.7 | 2.2 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 0.7 | 3.0 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.7 | 3.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.7 | 7.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.7 | 2.2 | GO:0004108 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 0.7 | 5.8 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.7 | 8.0 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.7 | 9.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.7 | 29.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.7 | 9.3 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.7 | 2.9 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.7 | 12.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.7 | 14.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.7 | 2.1 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.7 | 3.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.7 | 11.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.7 | 7.6 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.7 | 19.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.7 | 6.2 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.7 | 14.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.7 | 0.7 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.7 | 4.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.7 | 4.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.7 | 4.7 | GO:0042806 | fucose binding(GO:0042806) |
| 0.7 | 10.0 | GO:0030546 | receptor activator activity(GO:0030546) |
| 0.7 | 8.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.7 | 20.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.7 | 2.6 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.7 | 0.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.7 | 4.6 | GO:0043426 | MRF binding(GO:0043426) |
| 0.7 | 2.6 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.7 | 9.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.6 | 5.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.6 | 5.8 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) maltose alpha-glucosidase activity(GO:0032450) |
| 0.6 | 7.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 0.6 | 5.7 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.6 | 5.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.6 | 7.6 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.6 | 5.1 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.6 | 8.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.6 | 4.3 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.6 | 3.7 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.6 | 1.2 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 0.6 | 4.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.6 | 1.8 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.6 | 3.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.6 | 11.0 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.6 | 0.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.6 | 6.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.6 | 4.2 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.6 | 0.6 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.6 | 9.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.6 | 5.4 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.6 | 13.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.6 | 13.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.6 | 0.6 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
| 0.6 | 22.0 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.6 | 13.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.6 | 21.3 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.6 | 1.8 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 0.6 | 4.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.6 | 1.8 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.6 | 4.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.6 | 2.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.6 | 1.8 | GO:0046790 | virion binding(GO:0046790) |
| 0.6 | 4.7 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.6 | 52.9 | GO:0019003 | GDP binding(GO:0019003) |
| 0.6 | 6.9 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.6 | 2.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.6 | 4.6 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.6 | 1.7 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
| 0.6 | 5.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.6 | 2.8 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.6 | 2.3 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.6 | 18.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.6 | 2.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.6 | 6.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.6 | 18.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.6 | 341.4 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.6 | 2.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.6 | 11.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.6 | 2.2 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.6 | 1.1 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 0.6 | 12.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.6 | 0.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.5 | 2.2 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.5 | 2.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.5 | 7.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.5 | 9.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.5 | 8.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.5 | 23.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.5 | 4.8 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.5 | 34.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.5 | 6.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.5 | 0.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.5 | 26.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.5 | 11.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.5 | 5.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.5 | 0.5 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.5 | 5.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.5 | 2.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.5 | 1.0 | GO:0009374 | biotin binding(GO:0009374) |
| 0.5 | 10.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.5 | 4.6 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
| 0.5 | 3.0 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.5 | 3.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.5 | 5.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.5 | 9.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.5 | 9.4 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.5 | 26.9 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.5 | 1.9 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.5 | 6.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.5 | 1.4 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
| 0.5 | 5.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.5 | 1.9 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.5 | 7.5 | GO:0005537 | mannose binding(GO:0005537) |
| 0.5 | 0.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.5 | 1.4 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 0.5 | 2.8 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.5 | 1.4 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.5 | 0.5 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.5 | 0.9 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 0.5 | 6.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.5 | 33.0 | GO:0070888 | E-box binding(GO:0070888) |
| 0.5 | 3.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.4 | 66.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.4 | 1.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.4 | 1.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.4 | 5.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.4 | 1.8 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.4 | 4.0 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.4 | 1.8 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.4 | 10.1 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.4 | 1.7 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.4 | 3.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.4 | 3.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.4 | 7.4 | GO:0048185 | activin binding(GO:0048185) |
| 0.4 | 14.7 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.4 | 15.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.4 | 3.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.4 | 1.7 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.4 | 2.5 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.4 | 1.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.4 | 1.3 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.4 | 5.4 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.4 | 1.2 | GO:0035473 | lipase binding(GO:0035473) |
| 0.4 | 8.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
| 0.4 | 4.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.4 | 6.6 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.4 | 11.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.4 | 0.4 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
| 0.4 | 39.8 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.4 | 14.1 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
| 0.4 | 6.4 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.4 | 9.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.4 | 0.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.4 | 1.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.4 | 19.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.4 | 1.2 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.4 | 4.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.4 | 2.3 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 0.4 | 3.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.4 | 6.6 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.4 | 1.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.4 | 2.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 0.4 | 1.1 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 0.4 | 1.5 | GO:0035514 | DNA demethylase activity(GO:0035514) |
| 0.4 | 4.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.4 | 1.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.4 | 4.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.4 | 15.9 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.4 | 3.4 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.4 | 1.1 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.4 | 110.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.4 | 3.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.4 | 11.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.4 | 13.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.4 | 3.0 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.4 | 11.9 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.4 | 4.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.4 | 8.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.4 | 9.8 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.4 | 8.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.4 | 2.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.4 | 1.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.4 | 13.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.4 | 1.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.4 | 1.1 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.4 | 1.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.4 | 1.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.4 | 17.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.4 | 1.8 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.4 | 2.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.4 | 2.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 0.4 | 4.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.3 | 1.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.3 | 1.0 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 0.3 | 13.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.3 | 1.4 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.3 | 6.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.3 | 7.9 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.3 | 3.4 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.3 | 1.4 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.3 | 23.0 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.3 | 1.0 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.3 | 1.3 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
| 0.3 | 28.9 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.3 | 3.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.3 | 2.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.3 | 3.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.3 | 13.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.3 | 2.9 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.3 | 2.0 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.3 | 1.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.3 | 3.2 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.3 | 1.3 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.3 | 1.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.3 | 0.6 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.3 | 1.6 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.3 | 4.1 | GO:0015288 | porin activity(GO:0015288) |
| 0.3 | 0.6 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
| 0.3 | 0.3 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
| 0.3 | 1.9 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.3 | 0.9 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.3 | 8.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.3 | 8.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.3 | 7.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.3 | 4.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.3 | 2.4 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.3 | 1.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.3 | 1.5 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.3 | 3.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.3 | 25.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.3 | 1.4 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.3 | 2.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.3 | 2.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.3 | 61.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.3 | 2.2 | GO:0008443 | 6-phosphofructokinase activity(GO:0003872) phosphofructokinase activity(GO:0008443) |
| 0.3 | 1.1 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
| 0.3 | 6.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.3 | 2.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.3 | 6.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.3 | 1.4 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.3 | 2.7 | GO:0015250 | water channel activity(GO:0015250) |
| 0.3 | 0.8 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.3 | 1.1 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
| 0.3 | 1.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.3 | 4.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.3 | 0.8 | GO:0097003 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
| 0.3 | 1.3 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.3 | 1.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.3 | 1.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.3 | 3.4 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
| 0.3 | 7.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.3 | 1.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.3 | 2.1 | GO:0042835 | BRE binding(GO:0042835) |
| 0.3 | 1.3 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 0.3 | 2.9 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.3 | 1.6 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.3 | 3.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.3 | 1.6 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.3 | 1.0 | GO:1990175 | EH domain binding(GO:1990175) |
| 0.3 | 2.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.3 | 2.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.3 | 2.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.3 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
| 0.3 | 27.8 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.3 | 1.0 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 0.3 | 1.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.3 | 4.5 | GO:0004559 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
| 0.3 | 5.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.2 | 0.7 | GO:0061599 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
| 0.2 | 0.7 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.2 | 6.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.2 | 2.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.2 | 1.0 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.2 | 1.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.2 | 1.7 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.2 | 4.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.2 | 62.8 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.2 | 1.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.2 | 6.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.2 | 1.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
| 0.2 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.2 | 0.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.2 | 0.5 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.2 | 11.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.2 | 5.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.2 | 2.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.2 | 2.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.2 | 4.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.2 | 2.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.2 | 1.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.2 | 3.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.2 | 3.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.2 | 1.3 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.2 | 8.0 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.2 | 0.7 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.2 | 3.3 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.2 | 0.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.2 | 0.7 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.2 | 0.6 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.2 | 2.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.2 | 1.7 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.2 | 2.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.2 | 2.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.2 | 2.1 | GO:0003917 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
| 0.2 | 5.3 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.2 | 12.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.2 | 0.6 | GO:0047017 | prostaglandin-F synthase activity(GO:0047017) |
| 0.2 | 4.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.2 | 4.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.2 | 3.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.2 | 7.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.2 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.2 | 0.6 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.2 | 2.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.2 | 2.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.2 | 2.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.2 | 1.4 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.2 | 1.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.2 | 5.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.2 | 0.6 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.2 | 0.4 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.2 | 7.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.2 | 1.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.2 | 0.8 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 0.2 | 1.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.2 | 1.0 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.2 | 3.6 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.2 | 0.6 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.2 | 3.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.2 | 0.6 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
| 0.2 | 0.4 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.2 | 1.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.2 | 1.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.2 | 1.5 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
| 0.2 | 1.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.2 | 0.7 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.2 | 1.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.2 | 1.1 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.2 | 3.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
| 0.2 | 0.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.2 | 0.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.2 | 3.7 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.2 | 2.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.2 | 5.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.2 | 0.3 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 0.2 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.2 | 0.9 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.2 | 44.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.2 | 0.9 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.2 | 0.5 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.2 | 0.5 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.2 | 0.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.2 | 3.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.2 | 0.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.2 | 2.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.2 | 1.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.2 | 10.4 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
| 0.2 | 0.7 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.2 | 14.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.2 | 0.7 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
| 0.2 | 1.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.2 | 1.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.2 | 0.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 0.2 | 0.6 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.2 | 3.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.2 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.2 | 3.7 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.2 | 1.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.2 | 0.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.2 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.2 | 3.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.2 | 7.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.2 | 0.9 | GO:0070026 | nitric oxide binding(GO:0070026) |
| 0.2 | 0.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.2 | 0.8 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
| 0.2 | 0.8 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
| 0.2 | 4.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.2 | 0.3 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.2 | 0.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.2 | 0.5 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
| 0.2 | 5.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 3.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 7.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 0.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.1 | 1.0 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 1.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.1 | 1.5 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.1 | 0.7 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.1 | 1.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.1 | 2.6 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.1 | 4.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 6.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 0.4 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
| 0.1 | 1.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.1 | 0.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.1 | 1.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.1 | 0.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.1 | 0.1 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.1 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 2.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.1 | 0.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.1 | 1.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.1 | 3.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.8 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 0.1 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.1 | 2.5 | GO:0017022 | myosin binding(GO:0017022) |
| 0.1 | 2.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.1 | 0.8 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 0.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 4.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.1 | 0.6 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.1 | 0.4 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.1 | 1.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.1 | 1.1 | GO:0031432 | titin binding(GO:0031432) |
| 0.1 | 4.6 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.1 | 2.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 0.2 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.1 | 0.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.1 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 22.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.1 | 1.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.1 | 3.9 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
| 0.1 | 0.7 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.1 | 0.3 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 0.1 | 1.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.1 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.1 | 0.3 | GO:0035643 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
| 0.1 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.1 | 1.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 0.3 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
| 0.1 | 6.8 | GO:0033558 | protein deacetylase activity(GO:0033558) |
| 0.1 | 1.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 16.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 0.2 | GO:0019209 | kinase activator activity(GO:0019209) |
| 0.1 | 1.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 0.1 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 0.1 | 0.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.1 | 0.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
| 0.1 | 0.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.1 | 28.1 | GO:0005525 | GTP binding(GO:0005525) |
| 0.1 | 0.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 2.1 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.1 | 0.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 0.4 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.1 | 0.3 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.1 | 0.5 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.1 | 3.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 0.4 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.1 | 0.4 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.1 | 0.5 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.1 | 0.8 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 0.1 | 1.0 | GO:0010181 | FMN binding(GO:0010181) |
| 0.1 | 0.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.1 | 0.9 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.1 | 0.3 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.1 | 0.3 | GO:0036122 | BMP binding(GO:0036122) |
| 0.1 | 1.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.1 | 13.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 1.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.1 | 0.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.1 | 2.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 1.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.1 | 1.8 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.1 | 0.4 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.1 | 2.5 | GO:0030553 | cGMP binding(GO:0030553) |
| 0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.1 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.1 | 0.3 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.1 | 1.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.1 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 3.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.1 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.1 | 0.3 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.1 | 0.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.1 | 37.5 | GO:0003779 | actin binding(GO:0003779) |
| 0.1 | 0.2 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 0.1 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.1 | 0.2 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.1 | 19.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.1 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.1 | 0.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.1 | 1.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 0.7 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.1 | 0.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.1 | 0.2 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
| 0.1 | 0.5 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.1 | 1.0 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
| 0.1 | 1.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 1.6 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
| 0.1 | 0.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 0.4 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
| 0.1 | 0.8 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.1 | 0.4 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.1 | 0.2 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.1 | 0.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 3.1 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.1 | 0.4 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.1 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.1 | 0.2 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.1 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.1 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.1 | 0.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.1 | 1.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 4.3 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
| 0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.1 | 0.2 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.1 | 1.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 0.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.0 | 0.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.0 | 0.2 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.0 | 0.1 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.0 | 0.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.0 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.0 | 0.0 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.0 | 0.4 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.0 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.0 | 0.2 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.0 | 0.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.0 | 0.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.0 | 0.2 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.0 | 0.9 | GO:0016896 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
| 0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
| 0.0 | 0.2 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.0 | 0.2 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.0 | 0.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.0 | 0.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.0 | 0.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.0 | 2.5 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.0 | 0.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.0 | 0.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.0 | 0.2 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
| 0.0 | 0.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 0.2 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
| 0.0 | 0.9 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
| 0.0 | 0.2 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.0 | 0.1 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
| 0.0 | 0.4 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
| 0.0 | 0.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.0 | 1.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.0 | 0.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.0 | 2.3 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.0 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.0 | 1.3 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
| 0.0 | 3.6 | GO:0042393 | histone binding(GO:0042393) |
| 0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.0 | 0.1 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.0 | 0.1 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.0 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.0 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.0 | 0.1 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
| 0.0 | 6.5 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.0 | 0.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.0 | 3.0 | GO:0008022 | protein C-terminus binding(GO:0008022) |
| 0.0 | 0.9 | GO:0019902 | phosphatase binding(GO:0019902) |
| 0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.0 | 0.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.0 | 0.5 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
| 0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.0 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.0 | 0.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.0 | 0.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.0 | 0.0 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.0 | 0.7 | GO:0042562 | hormone binding(GO:0042562) |
| 0.0 | 0.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.0 | 0.0 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.0 | 0.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.0 | 0.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.0 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.0 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.0 | 0.0 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
| 0.0 | 0.0 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.0 | 0.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 39.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 1.2 | 15.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 1.2 | 77.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 1.2 | 68.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 1.1 | 7.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 1.1 | 98.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 1.1 | 3.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 1.0 | 3.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.9 | 79.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.9 | 63.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.9 | 21.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.9 | 28.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.7 | 27.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.7 | 5.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.7 | 6.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.7 | 6.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.7 | 14.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.7 | 43.7 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.7 | 10.7 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.7 | 84.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.6 | 33.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.6 | 54.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.6 | 39.4 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.6 | 25.4 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.6 | 27.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.6 | 1.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.5 | 36.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.5 | 25.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.5 | 6.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.5 | 67.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.5 | 1.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.5 | 8.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.5 | 8.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.4 | 33.1 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.4 | 6.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.4 | 7.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.4 | 1.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.4 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.4 | 6.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.4 | 12.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.4 | 17.1 | PID FOXO PATHWAY | FoxO family signaling |
| 0.4 | 7.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.4 | 14.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.4 | 40.3 | PID P73PATHWAY | p73 transcription factor network |
| 0.4 | 15.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.3 | 17.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.3 | 2.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.3 | 7.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.3 | 17.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.3 | 4.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.3 | 18.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.3 | 11.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.3 | 5.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.3 | 9.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.3 | 6.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.3 | 24.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.3 | 14.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.3 | 13.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.3 | 10.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.3 | 3.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.3 | 2.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.3 | 13.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.3 | 5.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.3 | 51.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.3 | 6.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.3 | 17.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.3 | 5.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.3 | 2.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.3 | 1.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.3 | 2.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.3 | 7.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.3 | 26.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.3 | 6.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.3 | 6.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.2 | 3.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.2 | 1.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.2 | 4.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.2 | 12.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.2 | 5.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.2 | 0.7 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.2 | 2.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.2 | 6.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.2 | 9.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.2 | 9.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.2 | 51.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.2 | 3.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.2 | 3.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.2 | 1.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.2 | 5.7 | PID ATM PATHWAY | ATM pathway |
| 0.2 | 2.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.2 | 5.1 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.2 | 6.6 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.2 | 1.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.2 | 5.7 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.2 | 1.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.1 | 1.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.1 | 44.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 15.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.1 | 3.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.1 | 6.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 8.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 2.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.1 | 0.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 0.7 | PID MYC PATHWAY | C-MYC pathway |
| 0.1 | 8.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 2.7 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.1 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.0 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 1.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
| 0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.0 | 0.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.1 | 6.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 2.0 | 47.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 1.9 | 1.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 1.7 | 32.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 1.6 | 40.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 1.4 | 58.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 1.3 | 26.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 1.1 | 17.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 1.1 | 9.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 1.1 | 34.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 1.0 | 50.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 1.0 | 6.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 1.0 | 25.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.9 | 30.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.9 | 22.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.9 | 12.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.8 | 26.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.8 | 23.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.8 | 21.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.8 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.7 | 7.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.7 | 21.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.7 | 25.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.7 | 17.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.7 | 17.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.7 | 6.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.7 | 27.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.7 | 5.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.6 | 40.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.6 | 16.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.6 | 4.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
| 0.6 | 12.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.6 | 14.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.6 | 12.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.5 | 22.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.5 | 4.4 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
| 0.5 | 6.9 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.5 | 10.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.5 | 16.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.5 | 15.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.5 | 11.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.5 | 13.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.5 | 14.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.5 | 25.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.5 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.5 | 27.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.5 | 13.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.5 | 3.7 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.5 | 19.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.4 | 8.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.4 | 4.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.4 | 7.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.4 | 1.7 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
| 0.4 | 25.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.4 | 16.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.4 | 41.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.4 | 9.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.4 | 3.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.4 | 22.5 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
| 0.4 | 1.6 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.4 | 15.5 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
| 0.4 | 4.3 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
| 0.4 | 5.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.4 | 14.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.4 | 11.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.4 | 10.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.4 | 6.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.4 | 5.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.4 | 27.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.4 | 11.4 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.3 | 8.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.3 | 5.4 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
| 0.3 | 1.7 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
| 0.3 | 2.6 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.3 | 2.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
| 0.3 | 4.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.3 | 6.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.3 | 8.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.3 | 13.8 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
| 0.3 | 3.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.3 | 3.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.3 | 13.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.3 | 3.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.3 | 1.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.3 | 5.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.3 | 9.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.3 | 9.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.3 | 7.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.3 | 4.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.3 | 6.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.3 | 4.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.3 | 20.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.3 | 1.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.3 | 43.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.3 | 24.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.3 | 5.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 5.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.2 | 7.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.2 | 10.8 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.2 | 10.2 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.2 | 3.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.2 | 3.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.2 | 6.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.2 | 12.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.2 | 10.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.2 | 22.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.2 | 5.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.2 | 9.5 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
| 0.2 | 10.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.2 | 4.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.2 | 8.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.2 | 7.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.2 | 2.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.2 | 22.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.2 | 3.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.2 | 3.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.2 | 4.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.2 | 18.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.2 | 5.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
| 0.2 | 2.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.2 | 4.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.2 | 4.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 36.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 1.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.1 | 0.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.1 | 1.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 13.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.1 | 0.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.1 | 2.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 3.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.1 | 3.7 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.1 | 4.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.1 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.1 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.1 | 3.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 0.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.1 | 0.5 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.1 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.1 | 2.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 1.3 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.1 | 0.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.1 | 2.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 2.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.1 | 1.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.1 | 5.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 0.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 2.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.1 | 2.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.1 | 0.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.1 | 35.0 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.1 | 1.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 1.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.1 | 6.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.1 | 1.4 | REACTOME MEIOSIS | Genes involved in Meiosis |
| 0.1 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.1 | 23.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 1.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.1 | 0.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 1.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
| 0.1 | 2.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.1 | 3.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 0.5 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
| 0.1 | 10.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.1 | 1.2 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
| 0.1 | 4.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.0 | 1.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.0 | 1.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.0 | 0.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.0 | 0.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 0.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.0 | 0.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.0 | 0.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.0 | 1.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.0 | 0.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.0 | 0.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.0 | 0.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.0 | 0.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 0.4 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |